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Abstract 
Tomato product consumption is epidemiologically associated with a decreased risk of 
cardiovascular disease as well as several cancers, and is most strongly associated with decreased 
prostate cancer risk.  Tomatoes contain a complex milieu of nutrients and bioactive compounds 
including the carotenoids lycopene (LYC), phytoene (PE), and phytofluene (PF).  Much 
emphasis has been placed on the bioactivity of LYC, but emerging research suggests that the 
colorless carotenoids, PE and PF, are bioactive and significantly accumulate in human and 
animal model tissues.  To elucidate the absorption and metabolism of these tomato carotenoids, 
an in vitro plant cell culture system for production of isotopically labeled carotenoids was 
developed, and absorption and biodistribution studies were performed in a relevant animal 
model, the Mongolian gerbil (Meriones unguiculatus).   
 To enhance 14C-carotenoid production from tomato (Solanum lycopersicum cv. VFNT 
cherry) in vitro cell suspension cultures were treated with two bleaching herbicides during the 
culture incubation, 2-(4-chlorophenyl-thio) triethylamine and norflurazon separately or in 
combination, to produce varying ratios of PE, PF, and LYC (CPTA, 1:2:18; norflurazon, 11:5:1; 
combination, 6:1:4, respectively).  Treatment with both herbicides resulted in optimal production 
of all three carotenoids (1.24 mg LYC/L, 1.74 mg PE/L, and 0.31 mg PF/L).  Subsequently, 
cultures were incubated in [14C]-sucrose-containing media to produce labeled LYC, PE, and PF. 
The impact of the timing of14C-sucrose addition was evaluated in norflurazon-treated cultures, 
and adding [14C]-sucrose on day 1 of the 14-d culture incubation cycle to led to a small increase 
in labeling efficiency compared to adding it on day 7.  In short, for optimal label incorporation, 
cultures should be grown with labeled carbohydrate for the duration of the growth cycle.  
Further, if primarily PE and PF are needed, norflurazon treatment should be used, for LYC 
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accumulation CPTA should be administered, and to obtain a mixture of PE, PF, and LYC, 
cultures should be grown with a combination of CPTA and norflurazon.  
 A second in vitro tomato cell culture study identified high LYC-producing cell line for 
[13C]-carotenoid production.  Different Solanum lycopersicum allelic variants for high LYC and 
varying herbicide treatments were compared for carotenoid accumulation in callus and 
suspension culture.  The gh tomato cell cultures produced more PE (3.5 mg/L) without the 
addition of norflurazon than that previously reported for VFNT cultures treated with norflurazon 
(2.1 mg/L), making it a preferred culture system for labeled PE production. When the hp-1cell 
cultures were treated with herbicides, they produced greater total carotenoids (3.6-5.2 mg/L) than 
the previously used VFNT cherry tomato cell line, and therefore hp-1 cell suspension culture 
system was chosen for isotopic labeling.  When grown with [U]-[13C]-glucose and treated with 
CPTA for LYC production, hp-1 suspensions yielded highly enriched 13C-LYC, with 45% LYC 
in the M+40 form, and 88% in the M+35 to M+40 isotopomer range.  In conclusion, the hp-1 cell 
line is preferable to other allelic variants or the VFNT cherry cell line for labeled tomato 
carotenoid production.  
 Lastly, the gerbil was utilized as a model of tomato carotenoid absorption and 
bioavailability.  The tomato carotenoids PE, PF, LYC, and zeta-carotene (ZC) were all absorbed 
from a 10% tomato powder diet and were differentially distributed to tissues at physiologically 
relevant levels compared to those previously reported for human tissues.  Further, although LYC 
was much more concentrated in the tomato powder diet, the tomato carotenoids accumulated in 
tissues at similar concentrations.  When unlabeled PE and LYC doses were provided to tomato 
powder-fed gerbils (LYC dose, 1.31 ± 0.05 mg in 206 ± 3 !L cottonseed oil; PE dose, 1.00 ± 
0.01 mg in 202 ± 3 !L cottonseed oil), PE was more readily absorbed (serum PE increased by 
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570% versus serum Z-LYC 90% and E-LYC 40% at 6 hr post-dosing).  PE dosing led to greater 
increases in liver PE at 6, 12, and 24 hours postdosing (81, 68, and 113%, respectively) 
compared to the respective increase in liver LYC after LYC dosing (-12, 20, and 0%, 
respectively).  In conclusion, although the prominent tomato carotenoids structurally differ only 
by number of double bonds, absorption and bioaccumulation of these carotenoids differs 
substantially. These results warrant future studies into the differential bioavailability and 
metabolism of tomato carotenoids in mammals by utilizing isotopically labeled tracers.  
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CHAPTER 1: 
 Literature Review 
 
Introduction 
 Consumption of tomato-based foods is linked to a decreased risk of chronic diseases, 
especially prostate cancer and cardiovascular disease (CVD).  While the red carotenoid lycopene 
(LYC) appears to be important for disease prevention, other colorless carotenoids, such as 
phytoene (PE) and phytofluene (PF) found at high concentrations in tomatoes are likely 
important.  However, at this time, little is known about the bioavailability (the proportion of 
consumed, intact carotenoid that appears in the circulation) bioaccumulation (the amount of 
consumed, intact carotenoid found in tissues), and metabolism (the chemical modifications to a 
carotenoid for utilization or clearance) of these red and colorless tomato carotenoids in humans 
and animal models, largely due to a lack of commercially-available isotopic tracers.  Tomato 
plant cell cultures provide an option for production of labeled carotenoids for use in humans and 
animals to track their absorption and metabolism. 
Tomato consumption prevents chronic disease progression in humans 
 In 2009, CVD was the primary cause of death for Americans, followed by cancer.  
Prostate cancer was the most frequently diagnosed cancer in men, and the second leading cause 
of cancer death after lung cancer (1, 2).  Both of these diseases are impacted by nutritional and 
environmental factors, therefore, nutritional intervention for disease prevention and attenuation is 
of great interest.   
 CVD is an umbrella term given for a cluster of diseases, which "includes coronary heart 
disease (CHD) (myocardial infarction, angina pectoris, coronary insufficiency/death), 
cerebrovascular diseases (stroke and transient ischemic attacks), peripheral vascular disease, 
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congestive heart failure, hypertension, and valvular and congenital heart disease (3)."  Strong 
epidemiological evidence has emerged to demonstrate the risk factors for developing CHD 
include age, male gender, high serum low-density lipoprotein and low high-density lipoprotein 
cholesterol, cigarette smoking, and diabetes mellitus. In addition to these risk factors, building 
evidence indicates that lifestyle, genetic factors, and diet are important modulators of CHD risk 
(3).  Over 40% of deaths in Western countries can be attributed to CVD, and this increased 
mortality compared to non-Western countries may be partially attributable to differences in 
lifestyle (4).   
 The pathophysiology of CVD is believed to include such processes as oxidative stress, 
endothelial dysfunction, inflammation, and vascular remodeling; therefore, reduction of the 
initial oxidative insults that begin the course of damage is important.  Generally, the initial 
oxidative damage occurs because of excessive reactive oxygen species (ROS).  ROS are believed 
to oxidize LDL, which may eventually lead to atherosclerosis- the precursor condition for stroke 
and heart attack (3).  Dietary antioxidants, such as carotenoids, are hypothesized to act in 
addition to endogenously-produced antioxidants to diminish the initial oxidative stress which 
leads to CVD pathology (3).  LYC is a powerful antioxidant in vitro and some studies examining 
tomato-based food consumption have shown short-term decreases in LDL oxidation. 
Additionally, one tomato extract supplementation trial reported a modest hypocholesterolemic 
effect (3), therefore tomato consumption may reduce CVD risk (5).  Several epidemiological 
studies have suggested that increased LYC concentrations in adipose and serum are inversely 
related to intimal wall thickness, intima-media thickness, and the risk of myocardial infarction, 
CVD, and atherosclerosis of the carotid artery and the aorta.  A nested case-control study of 
women found that plasma LYC levels were inversely correlated with CVD incidence over a 7-
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year follow-up period, whereas studies of men were more heterogeneous.  One nested case-
control study demonstrated that plasma LYC levels in men were not associated with CVD risk, 
while another revealed a positive relationship with myocardial infarction, and a third displayed 
an inverse association with stroke risk.  When dietary LYC was examined in the Women's 
Health Study, there was a weak inverse association with CVD incidence, however tomato-
product consumption was more strongly inversely associated with CVD than dietary LYC (these 
epidemiological studies are summarized in (5)).  In conclusion, a number of studies examining 
an association between tomato product consumption and risk or markers of cardiovascular 
disease risk were reviewed, and these indicated an inverse association between CVD and plasma, 
serum, and adipose levels of LYC (4). Whether LYC is the bioactive component for attenuation 
of CVD or is just a marker for tomato consumption, however, remains unanswered by these 
studies.     
 More robust evidence for a benefit of tomato products and their phytochemicals is likely 
derived from data regarding cancer.  For example, the systematic review by the American 
Institute for Cancer Research (AICR) and World Cancer Research Fund (WCRF) documents 
considerable evidence linking tomato carotenoids, specifically LYC, and reduced cancer 
incidence (6).  Indeed, several cohort and case-control studies indicate that foods rich in 
carotenoids probably protect against mouth, pharynx, larynx, and lung cancers (6). Other 
evidence suggests that lung cancer (2) is likely reduced with increased dietary and serum or 
plasma carotenoids (6) and a series of studies in the “smoking ferret” model suggest that LYC 
may have chemopreventive properties against lung cancer (7). Other evidence and hypotheses 
exist for LYC and/or tomato phytochemicals in the prevention of skin, liver, and breast cancer 
(6).  
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 Perhaps the strongest data exists for a relationship between tomatoes, their carotenoids, 
and prostate cancer risk.  Epidemiological evidence from a study of the dietary patterns and 
disease incidences from the Health Professionals Follow-up Study indicates that tomato sauce, 
tomato, and pizza intake was significantly correlated with a decreased risk of prostate cancer (8).  
Clinical intervention and observational trials regarding tomato products and prostate cancer have 
been reviewed (9, 10) and have shown mixed, but mostly favorable results.  Based upon a review 
of all available human studies, AICR/ WCRF deemed “foods containing LYC probably protect 
against prostate cancer (6).”   
 Cancer is believed to be a result of oxidative damage to DNA as well as a result of 
genetic factors, exposure to environmental toxicants, deregulation of the cell cycle, a loss of cell-
cell communication, and altered hormone and growth factor signaling.  Various studies have 
examined the impact of tomatoes and LYC on these parameters with promising results that 
suggest that tomato products protect DNA, induce phase II detoxification enzymes, modulate 
hormone and growth factor signaling, induce cell cycle arrest, and increase gap junction 
communication (reviewed in (11)).  In contrast to the measured statement above by the 
WCRF/AICR specifying foods containing LYC, emphasis is often placed on LYC alone in 
research and product marketing.  It is important to note that many studies on LYC and health 
outcomes actually provide human subjects with a mixture of tomato carotenoids but refer to it 
only as “LYC supplementation.”  We believe it is of immediate importance to determine the 
contribution of the other bioactive phytochemical components in tomatoes. 
Tomato Nutrients and Bioactives  
 Tomatoes contain a complex mixture of bioactive components and nutrients making them 
part of a balanced diet, yet it is difficult to identify a single bioactive compound responsible for 
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potential health benefits.  Tomatoes serve as a dietary source of potassium, folate, and the 
vitamins A, C, and E (11).  Additionally they contain a mixture of carotenoids including LYC, !-
carotene, PE, neurosporene, PF, "-carotene, #-carotene, and lutein (12). There are over 600 
carotenoids found in nature, and they are generally colorful orange, red, and yellow pigments 
synthesized by photosynthetic plants, bacteria, and fungi.  These tetraterpenes usually consist of 
8 isoprene units derived from isopentenyl diphosphate (IPP), the same precursor required for 
cholesterol synthesis in animals, however in plants carotenoids are synthesized in plastids via the 
1-deoxy-D-xylulose-5-phosphate (DOXP) pathway rather than the mevalonic acid pathway of 
cholesterol biosynthesis (13) (Figure 1.1). IPP condenses with dimethylallyl diphosphate 
(DMAPP) to yield geranylgeranyl diphosphate (GGPP), a C20 molecule, which subsequently 
condenses with another GGPP via phytoene synthase to give the carotenoid precursor PE.  Then 
PE is sequentially, enzymatically desaturated to first yield PF and eventually LYC (13).  During 
early ripening of the tomato fruit, DOXP synthase expression, as well as phytoene synthase 
mRNA levels increase, while lycopene cyclase (the enzyme responsible for cyclizing LYC to 
yield #-carotene) levels decrease.  Because carotenogenesis is intimately tied to ripening 
processes, any "biotic or abiotic factor" that impacts tomato ripening "such as genotype, fruit 
maturity level, cultivation practice, and environmental conditions" will effect the carotenoid 
profile present in the tomato (14).  Carotenoids are not the only compounds impacted by these 
factors which promote ripening, but other nutrients and bioactives such as tocopherols, folates, 
phenolics, glycoalkaloids, flavonoids, and vitamin C also vary by ripening stage (14-16) 
Prostate cancer and tomato consumption in rats 
 Based on epidemiological associations for LYC and prostate cancer, our lab sought to 
determine if LYC alone was responsible for disease prevention or if the mixture of bioactives 
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found in tomatoes is important.  Our lab found tomato powder to be more effective than purified 
LYC beadlets in both slowing implanted prostate tumor growth or decreasing chemically-
induced tumor incidence in rats (17, 18).  These findings suggest that LYC alone is not solely 
responsible for disease prevention and amelioration, but that other components in tomatoes are 
bioactive. 
 There are many proposed mechanisms for LYC-mediated cancer prevention such as 
induction of phase II enzymes, suppression of cell proliferation, antioxidant protection, and 
upregulation of gap-junction communication (19).  To isolate the role of LYC compared to the 
whole tomato, ex vivo assays compared the effect of feeding LYC beadlets to the effect of 
feeding rats red (LYC-rich) or yellow (LYC devoid) tomato-containing diets on biomarkers of 
oxidative stress and induction of connexin 43, a gap junction protein (20, 21).  In both studies, 
rats were fed diets for 6 wk supplemented with LYC beadlets (50 mg LYC/kg diet), red tomato 
powder (50 mg LYC/kg diet), yellow tomato powder (0 mg LYC/kg diet), or the basal diet, 
which contained 1/3 of the vitamin E requirement.  The sera of the rats were added to the media 
of human prostate cancer cells, and the sera from rats fed yellow or red tomatoes significantly 
stimulated connexin 43 protein levels compared to the sera from LYC beadlet and control-fed 
animals (21).  Similarly, when heart tissue homogenates from these rats were subjected to lipid 
peroxidation, yellow and red tomato-fed rats were protected compared to LYC beadlet and 
control powder feeding (20).  Taken together, these studies suggest that a combination of tomato 
phytochemicals is important in putative anti-cancer mechanisms compared to LYC alone, and 
further that LYC-free tomato powder is as effective as LYC-containing powder for gap-junction 
protein stimulation and antioxidant protection. 
 
 7 
Phytoene, phytofluene, and lycopene 
 As discussed above, whole tomato powder was more effective than LYC alone in the 
previously-discussed animal studies likely because of the many nutrients and phytochemicals 
found in whole tomatoes, especially two colorless carotenoids, PE and PF.  For the field of 
disease-risk reduction with tomato consumption to move forward, we believe PE and PF must be 
investigated more in depth.  These carotenoids have been largely overlooked because they are 
colorless, however they are present in amounts similar to LYC in fresh tomatoes with 
concentrations of 2.6 mg LYC, 1.9 mg PE, and 0.8 mg PF per 100 g (11). 
 Current knowledge of PE and PF in humans is limited to the following observations A.) 
they are absorbed from tomato foods and extracts and B.) they accumulate in cells and tissues.  
When subjects consumed ~5 mg PF/d for 4 wk from a tomato juice, they experienced a 
significant increase of serum and buccal mucosal cell PF which was comparable to LYC 
accumulation although there was ~ 15-fold more LYC in the juice  (22).  In a similar study 
where subjects received the same high LYC tomato juice (75 mg LYC, 5 mg PF, and 6 mg PE/d) 
for 4 wk, PE and LYC increased in plasma by 0.19 and 0.17 µmol/L while PF increased by 0.45 
µmol/L (23).  PE and PF have been detected at similar concentrations as LYC, in liver, lung, 
breast, prostate, colon, and skin tissue as well, notably with PE appearing at levels 4-fold higher 
than that of LYC in lung tissue (12). 
 Our lab found that human prostate cancer cells absorb PE and its breakdown products in 
vitro (24).  We also found that in rats, PE and PF are absorbed, accumulate more in some tissues 
than in others, and PF may be absorbed more readily than LYC (25), confirming the interesting 
results seen in humans provided a low amount of PF daily in high LYC tomato juice (22).  When 
tomato powders of differing PE, PF, and LYC profiles were fed to rats for 7 d, different total 
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amounts of carotenoids and different ratios of PE, PF, and LYC accumulated in tissues 
suggesting differential absorption and metabolism of these compounds (26).   
 With regards to bioactivity, short-term exposure (4-d feeding) to PF, LYC, and tomato-
powder feeding decreased androgen status in rats, which could be important for hormone-
dependent prostate cancer (27).  There is also evidence that PE and PF, like LYC, inhibit LDL 
oxidation in vitro, which may translate to protection from oxidative stress (28).  When mouse 
embryonic fibroblasts (NIH3T3) were transfected with the phytoene synthase encoding gene 
crtB from Erwinia uredovora, the phytoene-producing mammalian cells were protected from 
oxidative stress as well as malignant transformation induced by oncogene transfection (29).  
Similarly, a transgenic crtB mouse showed increased connexin 26 expression, which may 
translate to increased cell-cell communication important for cancer prevention (30).   These 
results suggest that the bioactivity of PE and PF in humans is probable, but considerably more 
research is needed to support this assumption. 
Tomato carotenoid absorption and metabolism in humans 
 Carotenoid absorption and metabolism is an actively growing area of research.  Several 
studies have demonstrated that carotenoids are absorbed along with dietary fats; indeed 
consumption of carotenoids with triglycerides, specifically those with long-chain fatty acids, 
enhances carotenoid absorption (31-33).  Bile is needed for the micellarization and subsequent 
absorption of carotenoids. Thus, since dietary fat stimulates bile secretion, carotenoid absorption 
efficiency is enhanced with fat consumption (34).  Currently, it is believed that carotenoid 
absorption into the enterocyte is facilitated via the scavenger receptor B type 1 (SRB-1) as well 
as by cluster determinant 36 (CD36).  Within the enterocyte, carotenoids are packaged into 
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chylomicrons and secreted into the lymph.  Carotenoids are shuttled in the plasma by 
lipoproteins and thus their biodistribution is dependent on proper apolipoprotein function (35).   
 Pharmacokinetic modeling of LYC absorption (transfer of carotenoids from the 
gastrointestinal lumen to the enterocyte and then into the blood circulation) and biodistribution 
from a tomato drink has been informative.  One human study indicated that regardless of LYC 
content in the drink (10mg/79 mL, 30 mg/238 mL, 60 mg/476 mL, 90 mg/769 mL, or 
120mg/797mL), the same amount of LYC was absorbed (4.69± 0.55 mg), suggesting saturation 
of absorptive mechanisms.  Different tissue compartments were included in a mathematical 
model developed to describe LYC absorption and biodistribution.  Based on the model 
generated, the liver was found to be the fast turnover tissue while other tissues that were resistant 
to LYC depletion, serving as the slow turnover pool (36).  Though PE and PF differ from LYC 
by only a few double bonds, some differences in their absorption and biodistribution have been 
observed.  First of all, when subjects were provided with a high LYC tomato juice for 4 wk (75 
mg LYC, 5 mg PF, 6 mg PE in 476 mL juice), they accumulated much higher plasma levels of 
PF (~0.6 µmol/L) than LYC (~0.2 µmol/L) and PE (~0.2 µmol/L).  Additionally, while LYC is 
primarily found in the LDL-containing blood fraction followed by the HDL fraction, PE and PF 
are primarily found in the LDL fraction and were relatively higher in the VLDL fraction than 
was LYC (23).  Similarly, when the same high LYC tomato juice was consumed for 4 wk in a 
different study, LYC and PF attained nearly equivalent levels in buccal mucosal cells despite 
their disparate levels in the juice (22).  The authors suggested that either the absorption 
efficiency or the metabolism of these tomato carotenoids differ (23).  However, it could also be 
that the absorption mechanisms are saturated for LYC at the 75 mg/d level as evidenced by 
pharmacokinetic research (36).  When a standard, commercially-available (lower LYC) tomato 
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juice (18 mg LYC, 2.1 mg PE, and 1.1 mg PF/d) was provided for 3 wk to humans, PF and LYC 
plasma concentrations increased the same amount (138 and 125%) while the increase in PE was 
lower (110%) (37). 
 Two carotenoid cleavage enzymes metabolize carotenoids.  Carotenoid monooxygenase 1 
(CMO1) is well known to centrally cleave pro-vitamin A carotenoids, such as #-carotene, at the 
15, 15' double bond to yield vitamin A (38).  Carotenoid monooxygenase 2 (CMO2) cleaves #-
carotene eccentrically (39), and it is hypothesized to lead to eccentric cleavage of other 
carotenoids such as LYC (40).  In fact, ferret CMO2 expressed in Spodoptera frugiperda cells 
effectively cleaved all-trans #-carotene as well as cis-LYC isomers (but not all-trans LYC) at 
the 9', 10' double bond (summarized in (19)).  Additionally, our lab has detected the LYC 
metabolites apo-8'-lycopenal and putatively apo-12'-lycopenal in the liver of rats fed LYC for 30 
d (41).  The CMO2 gene has been detected in an array of human tissues both co-occuring with 
CMO1 (small intestinal and stomach mucosa, Leydig and Sertoli cells in the testis, kidney 
tubules, adrenal gland, exocrine pancreas, and epithelium in the eye), as well as being expressed 
in tissues that do not express CMO1 (cardiac and skeletal muscle, prostate and endometrial 
connective tissue, and the endocrine pancreas) suggesting that CMO2 has a function independent 
of VA production (42).  Although more information on CMO2 is emerging, very little is known 
about the carotenoid cleavage products of this enzyme, and it is unknown if PE or PF are cleaved 
by CMO2. 
Pharmacokinetic carotenoid tracer research 
 Isotopically labeled (13C or 14C) carotenoid tracers allow a single carotenoid dose to be 
followed within pre-existing, endogenous pools.  This is especially important in dietary 
carotenoid metabolic research since these natural compounds are found widely in the diet of 
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Americans.  It is difficult to completely exclude carotenoids from the diet, as would be desired to 
conduct conventional pharmacokinetic and metabolic studies.  Previously, 13C or 14C tracers of 
lutein and #-carotene have been utilized to study absorption, plasma appearance, and endogenous 
pools of these specific carotenoids in humans.   Labeled lutein and #-carotene studies have 
provided information on these carotenoids regarding their absorption kinetics, isomerization of 
#-carotene during absorption, endogenous plasma pool quantification, and the conversion of #-
carotene to vitamin A (43-49).  Additionally, deuterium-labeled LYC obtained either by 
chemical synthesis or from intrinsically labeled tomatoes grown hydroponically were used to 
determine the relative bioavailability of LYC from steamed and pureed tomatoes versus synthetic 
LYC in oil. The results showed that synthetic LYC in oil was 3 times more bioavailable (50). 
Some pharmacokinetic LYC tracer research has been previously performed in rodents.  Two 
studies from our lab focused on the absorption and biodistribution of 14C-LYC in F344 rats (51, 
52).  When rats were fed 0.25 g LYC/kg diet for 30 d and then gavaged with a single oral dose of 
14C-LYC with unlabeled LYC (0.246 mg in oil), 7% of the dose was absorbed and 6% was 
retained over 168 hr.   Radiolabeled LYC was also used to determine that pre-feeding LYC, as 
opposed to a control diet, which decreased the amount of absorbed LYC (51). To date, no tracer 
studies on phytoene or phytofluene absorption kinetics, relative bioavailability, biodistribution, 
or metabolism have been performed in animals or humans and therefore we know very little 
about these prevalent dietary carotenoids. 
Carotenoid metabolism in gerbils 
 Recently, LYC absorption has been examined in the Mongolian gerbil (Meriones 
unguiculatus).  When F344 rats, BALB/c mice, nude mice, and gerbils were provided oral doses 
of LYC (20 mg/kg BW) every two days for 10 d, gerbils accumulated the greatest hepatic and 
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plasma LYC.  Additionally, in a subsequent experiment, the authors found that gerbils provided 
with the previously specified dose for 20 d (10 doses) achieved steady state plasma LYC 
concentration of 597 to 722 nmol/L after 6 days of supplementation (53).  Another study sought 
to compare LYC bioavailability from tomato paste powder, red carrot powder, and purified LYC 
in oil.  Each treatment provided ~60 !g LYC/d to the gerbils for 3 wk.  LYC was most 
bioavailable from the tomato paste powder, followed by the red carrot powder, and lastly the 
LYC in oil.  Further, several thousand times lower levels of LYC were detected in the testes and 
adrenals than in liver in response to the LYC-containing treatments, showing that carotenoid 
bioaccumulation patterns in gerbils are more similar to rats than humans.  Humans can 
accumulate up to 9-times the concentration of LYC in those tissues compared to the liver (54). 
 In addition to LYC absorption, gerbils have proven to be an excellent model for other 
carotenoids and for vitamin A absorption and metabolism research.  Similar to humans, gerbils 
absorb #-carotene intact, and convert #-carotene to vitamin A at a similar efficiency to humans 
(55).  Gerbils are also useful models for vitamin A status and vitamin A production from 
carotenoids.  The bioefficacy to serve as vitamin A precursors of #- and $-carotene in carrots, 
cassava, and maize have been assessed  using the gerbil as a model (56-60).  Additionally, 
gerbils are good models for evaluating effectors of carotenoid absorption and bioefficacy such as 
xanthophylls, dietary fat, and fiber (57, 61, 62).  Although we understand a great deal about 
gerbil pro-vitamin A carotenoid uptake and metabolism and are learning more about LYC, 
currently nothing is known about the absorption and distribution of PE and PF in gerbils. 
The gerbil as a model for prostate cancer and hypercholesterolemia 
 The Mongolian gerbil is not only an excellent model for carotenoid uptake and 
metabolism but is an established model of lipid metabolism and an emerging model of prostate 
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cancer.  The gerbil can be used to study spontaneous, age-related prostate lesions.  Gerbils, 
unlike other rodents, have a compact prostate (not divided into discrete lobes) similar to humans, 
but like other rodents they differ in the macro- and microscopic glandular anatomy compared to 
humans.  In aged (18 mo) gerbils, there is an 80% incidence of histopathological alterations 
mainly in the prostate epithelium.  The most frequent alteration was prostate intraepithelial 
neoplasia (PIN), being found in 47% of the affected prostates, followed by microinvasive 
carcinomas and adenocarcinomas (63).  Similar to previous studies in rats, testosterone in 
conjunction with chemical carcinogens can be used to induce prostate tumor development in 
gerbils, therefore, recent research investigated the potential of the gerbil to be used for prostate 
neoplasia induction and study (64).  The carcinogen N-methyl-N-nitrosurea was also used with 
or without testosterone treatment to induce prostate cancer in gerbils to study prostate cancer 
progression and the role of extracellular matrix component remodeling in cellular invasiveness 
(65).  The gerbil also was used to examine the effect of androgen depletion on androgen 
sensitivity in the prostate of senescent animals (66). 
 The gerbil has the most similar serum lipid profile to humans of any rodent and thus has 
been used for cholesterol and lipid metabolism research for over 40 years (67).  The impact of 
differing dietary lipid profiles on blood lipids has been elucidated using the gerbil (68-70), with 
recent emphasis on the effect of trans fats and phytosterols on plasma triglycerides and 
cholesterol (71-74).  Given the appropriateness of the gerbil as a model of hypercholesterolemia 
and prostate cancer, a unique opportunity is presented in using the gerbil as a model for tomato 
carotenoid consumption and disease prevention. 
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Biolabeled tracer production from plant cell culture 
 Further progress on mechanisms of tomato carotenoid metabolism has been hampered 
because there is no commercial source for isotopically labeled PE, PF, or LYC.  Tomato cell 
suspension cultures have proven to be an effective tool for the production of [14C]-radiolabeled 
carotenoids, which can be used for pharmacokinetic studies (24).  By determining the uptake and 
metabolism of tomato carotenoids, we can better understand the disease-phytochemical 
relationship. 
Plant cell culture is a useful method for radiolabeled bioactive compound production; 
grape polyphenols, berry anthocyanins, kudzu isoflavones, red clover isoflavones, and tomato 
carotenoids have been successfully biolabeled (24, 75-77).  Several advantages are offered by 
using plant cell culture rather than whole plants to accumulate radiolabeled metabolites, such as 
the ability to target selected tissue sources based on desired secondary metabolite production 
profiles, shortened culture periods, relative ease of extraction, aseptic growth conditions, and 
uniform exposure to isotopically labeled carbon sources in the media (76). 
 In order to enhance in vitro carotenogenesis, bleaching herbicides have been utilized (24, 
78-81).  Bleaching herbicides are chemicals that interrupt the normal biosynthesis of carotenoids, 
either in vivo or in vitro, causing a fatal loss of photoprotection in the plant, leading to the 
destruction of chlorophyll upon light exposure (82).  “Bleaching herbicide” is an umbrella term 
for several classes of herbicides such as substituted trialkyamines, phenylpyridazinone 
derivatives, and phenyl-substituted 6-methyl pyrimidines (82, 83).  Previously, our lab utilized 
the bleaching herbicide norflurazon to promote [14C]-PE and PF accumulation in tomato cells, 
and the tracers were used for in vitro investigation of their uptake into prostate cancer cells (24).  
Norflurazon is a phytoene desaturase (PDS) inhibitor, which inhibits the conversion of PE, the 
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first carotenoid in carotenogenesis, to PF (Figure 1.1) (81).  Further, norflurazon causes a 
concomitant increase in PDS expression as well as a modest increase in phytoene synthase (PSY) 
expression, likely due to increased photooxidative stress or a lack of end-product regulation of 
carotenogenesis (Figure 1.1) (84).  Campbell et al. previously determined that cv. VFNT cherry 
tomato cells produced the greatest amounts of PE (~634 µg/L culture) and PF (~88 µg/L culture) 
with 0.03 mg norflurazon/40 ml culture in a dimethyl sulfoxide (DMSO) carrier (0.07 % final 
media concentration), added on day 7 of the 14 day growth period (24).  
 The bleaching herbicide 2-(4-chlorophenyl-thio) triethylamine (CPTA) has also been 
widely used in in vitro tomato research for the study of LYC accumulation and ripening 
mechanisms (78-80).  CPTA, a synthetic tertiary amine, was first reported to induce LYC 
accumulation when applied to the surface of several fruits and vegetables that do not normally 
produce LYC such as oranges, carrots, yellow grapefruit, and sweet potatoes (85).  CPTA 
inhibits LYC cyclase (LCYC) causing LYC accumulation and a lack of downstream cyclic 
carotenoid production (Figure 1.1).  Cyclic carotenoids are believed to feedback inhibit 
carotenogenesis, therefore a lack of cyclic carotenoids may induce the promoter of the second 
committed enzyme in the carotenoid biosynthetic pathway, PDS (86). 
Conclusion 
 Tomato carotenoids are believed to play a significant preventative role in a variety of 
diseases, however little is known about their underlying biodistribution and metabolism in 
tissues.  In order to make useful dietary recommendations to Americans for CVD and prostate 
cancer prevention and management by tomato consumption, human clinical trials must be 
performed.  However, only with substantial knowledge of carotenoid bioavailability, 
biodistribution, and metabolism in appropriate animal models can such studies be properly 
 16 
designed.  To best observe carotenoid metabolism, sources of isotopically labeled carotenoids 
must be developed and a suitable animal model for metabolism is needed.  For these reasons, 
methods for producing labeled carotenoid tracers from plant cell cultures were established, and 
the Mongolian gerbil, an emerging model for tomato carotenoid metabolism, was employed.  
Research combining the tool of labeled tomato carotenoid tracers and the gerbil model of 
carotenoid absorption, metabolism, and biodistribution will contribute to this important area of 
nutritional modifications and disease prevention.  The overarching hypothesis laying a 
foundation for this work is that tomato carotenoids and their endogenously produced carotenoid 
metabolites are bioactive components that prevent or alleviate chronic disease.  Specifically for 
this dissertation, we hypothesize two prominent, colorless tomato carotenoids, PE and PF, along 
with red LYC are absorbed from the diet and are biodistributed into a variety of tissues. The 
major goals of this research are to A.) optimize a tomato cell culture production system for 
biolabeled carotenoids and B.) characterize tomato carotenoid absorption, bioavailability, and 
biodistribution in the Mongolian gerbil. 
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Figures 
 
Figure 1.1. Carotenoid biosynthetic pathway found in tomatoes. 
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CHAPTER 2: 
Herbicide Treatments Alter Carotenoid Profiles for 14C Tracer Production from Tomato 
(Solanum lycopersicum cv. VFNT cherry) Cell Cultures12  
 
Abstract 
 Progress in learning about underlying carotenoid bioactivity mechanisms has been 
limited because of the lack of commercially available radiolabeled lycopene (LYC), phytoene 
(PE), and phytofluene (PF). Tomato (Solanum lycopersicum cv. VFNT cherry) cell cultures have 
been treated to produce [14C]-PE and PF but with relatively low yields.  To increase carotenoid 
production, two bleaching herbicides were administered during the culture incubation, 2-(4-
chlorophenyl-thio)triethylamine and norflurazon separately or in combination to produce varying 
ratios of PE, PF, and LYC.  Treatment with both herbicides resulted in optimal production of all 
three carotenoids.  Subsequently, cultures were incubated in [14C]-sucrose-containing media to 
produce labeled LYC, PE, and PF. Adding [14C]-sucrose on day 1 of the 14-day culture 
incubation cycle to norflurazon-treated cultures led to a small increase in labeling efficiency 
compared to adding it on day 7.  Improved culture conditions efficiently provided sufficient 14C-
carotenoids for future cell culture and animal metabolic tracking studies.  
Introduction 
A substantial body of epidemiological evidence suggests that tomato consumption is associated 
with a decreased risk of a variety of cancers including lung, stomach, and prostate, with the 
strongest evidence for prostate cancer (1, 2).  Tomatoes provide many nutrients to the diet, 
                                                
1 This chapter was the result of a collaboration of the following authors: Nancy J. Engelmann, 
Randy B. Rogers, Mary Ann Lila, and John W. Erdman, Jr. 
2 Reproduced with permission from Engelmann, N.J.; Rogers, R.B.; Lila, M.A.; Erdman, J.W., 
Jr. Herbicide treatments alter carotenoid profiles for 14C tracer production from tomato 
(Solanum lycopersicum cv. VFNT cherry) cell cultures. J. Agric. Food Chem. 2009, 57, 4614-
4619. Copyright 2009. 
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including carotenoids, which are 40 carbon, pigmented compounds that range from colorless to 
red, yellow, and orange (3).  The most predominant carotenoid in red tomatoes is lycopene 
(LYC), followed in concentration by phytoene (PE), phytofluene (PF), #-carotene, $-carotene, 
and lutein and zeaxanthin (3).  These prominent carotenoids are believed to be critical to the 
efficacy of tomatoes to prevent disease; however the majority of disease prevention research 
focuses on LYC alone. 
To best understand the underlying mechanisms of prostate cancer risk reduction afforded 
by tomato consumption, a number of investigations into the bioavailability, biodistribution, and 
metabolism of tomato carotenoids have been undertaken (4-9).  Further progress on mechanisms 
has been hampered because there is no commercial source for isotopically labeled PE, PF, or 
LYC.   
Plant cell culture is a useful method for radiolabeled bioactive compound production, 
offering several advantages compared to whole plant biolabeling, such as the ability to target 
selected tissue sources based on desired secondary metabolite profiles, shortened culture 
periods, relative ease of extraction, and uniform exposure to isotopically labeled carbon sources 
in the media (10-14). 
 To enhance in vitro carotenogenesis, bleaching herbicides have been used (14-17).  
Bleaching herbicides interrupt normal carotenogenesis either in vivo or in vitro, causing a fatal 
loss of photoprotection in the plant, leading to chlorophyll destruction upon light exposure (18).  
Previously, the bleaching herbicide norflurazon (NORF) was used to promote 14C-PE and PF 
accumulation in tomato cv. VFNT cherry cells, and the tracers were used for in vitro 
investigation of their uptake into prostate cancer cells.  NORF is a phytoene desaturase (PDS) 
inhibitor, preventing conversion of PE, the first carotenoid in carotenogenesis, to PF (Figure 
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2.1) (15).  Further, NORF causes a concomitant increase in PDS expression as well as a modest 
increase in phytoene synthase (PSY) expression, likely because of the increased photo-oxidative 
stress or a lack of end-product regulation of carotenogenesis (Figure 2.1) (19).   
The bleaching herbicide 2-(4-chlorophenyl-thio)triethylamine (CPTA) has also been widely 
used in in vitro tomato research for the study of LYC accumulation and ripening mechanisms 
(16, 17, 20).  CPTA inhibits lycopene cyclase (LCYC), causing LYC accumulation and a lack of 
downstream cyclic carotenoid production (Figure 2.1).  Because CPTA seems to cause an 
overall increase in carotenogenesis, it was hypothesized that CPTA, in combination with the 
previously used NORF treatment, would yield greater PE and PF than NORF alone. 
Another goal of this study was to enhance the radiolabeling efficiency of targeted 
carotenoids. Plant secondary metabolites are produced during the growth plateau phase of cell 
culturing (21). Therefore, examining different [14C]-sucrose-dosing times during the growth 
cycle may lead to targeted enrichment of carotenoids. The timing effect of adding [14C]-sucrose 
with NORF on 14C enrichment of PE and PF was examined.   
Materials and Methods 
Tomato Cell Suspension Cultures and Herbicide Treatments.   
 Suspension cultures were initiated and maintained according to a previously described 
method using tomato cv. VFNT cherry calyces for callus initiation (17).  Friable callus was 
transferred from agar-solidified media to solution media and subsequently transferred to fresh 
media every 2 weeks using published media formulations and culturing methods (14).   
 To alter the carotenoid biosynthetic pathway, thus optimizing specific carotenoid 
accumulation, cell cultures were treated with herbicides.  A total of 80 mL of fresh media, 
containing indole-3-acetic acid (5 mg/L) and all trans zeatin (2 mg/L) growth regulators in 250 
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mL Erlenmeyer flasks, was inoculated with 8 mL of spent media and 4 mL of packed cells.  A 2 
x 2 factorial design for the herbicide treatment experiments was used. On the basis of previous 
work, herbicide treatments were as follows: cultures were either aseptically treated on day 1 with 
filter-sterilized aqueous CPTA (74.5 mg/L media, a gift from Betty K. Ishida, USDA-ARS, St. 
Albany, CA) on day 7 with filter-sterilized NORF (0.75 mg/L media, Syngenta, Greensboro, 
NC) dissolved in dimethylsufloxide (DMSO), with both herbicides on respective days, or with 
neither (control treatment) (14, 17).  Subsequently, for PE, PF, and LYC radiolabeling, cultures 
were treated with both CPTA and NORF, and for [14C]-sucrose dose timing experiments, cultures 
were treated with NORF only. 
14C Radiolabeling of Herbicide-Treated Suspension Cultures.   
 To safely and efficiently 14C-label carotenoids from tomato cell suspension cultures, cells 
were subcultured into a reduced volume of media (72 mL) and 8 mL of fresh media containing 
0.45 mCi/mL uniformly labeled [14C]-sucrose (10 mCi/mmol) (MP Biomedicals, Irvine, CA) was 
added on either day 1 or day 7 of the 14 day growth period.  The final radiolabel-specific activity 
was 45 µCi/mL fresh media.  Cultures were grown in a previously described enclosed Plexiglas 
radiolabeling chamber equipped with NaOH traps and an air-flushing system to prevent escape 
of 14CO2 from the growth chamber (12).  The growth environment was controlled. Rotary shakers 
were set to 160 rpm. The growing temperature was 22 °C. The cultures were grown in darkness. 
The chamber air was flushed 4 times per day.   
In CPTA-treated tomato cv. VFNT cherry cells, the majority of LYC is produced after 
the end of growth and continues to increase in concentration up to 32 days after inoculation (16).  
Preliminary studies (data not shown), indicated that when tomato cv. VFNT cherry cultures 
treated with CPTA were harvested at 14, 21, and 28 days, the LYC concentration increased over 
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time; however, harvest mass drastically decreased, resulting in an overall lower LYC yield at 21 
and 28 days compared to a 14 day culture duration.  For this reason a 14 day growth period was 
selected for further studies.  Because NORF is added on day 7 (as opposed to day 1 in the case of 
CPTA), carotenogenesis in NORF-only treated cultures is very low during the first 7 days of the 
14 day growth period.  It was hypothesized that adding [14C]-sucrose on day 7 of the growth 
cycle (rather than initially on day 1) would lead to increased 14C enrichment of PE and PF in 
NORF-treated cultures.   
Three, 14 day long [14C]-radiolabeling runs were conducted.  The first examined the 
carotenoid-labeling efficiency of CPTA- and NORF-treated cells with [14C]-sucrose (12 flasks) 
provided on day 1.  The next two runs (6 flasks/run) compared the effect of [14C]-sucrose dose 
timing (day 1 versus 7) on PE- and PF-labeling efficiency in NORF-only treated cultures. 
Suspension Culture Harvest.   
 Labeled and nonlabeled cultures were harvested on day 14 using Whatman #4 filters with 
a Büchner funnel over a vacuum.  Filtration was ended, and cultures were collected and weighed 
when no further liquid was expressed from the funnel for 30 s.  Samples of each flask (~1 g) 
were collected for further carotenoid and 14C scintillation analysis, and the remaining cells were 
combined for carotenoid preparatory extraction and isolation for future cell culture and animal 
metabolic studies.  When cultures were collected from the radiolabeling chamber, samples were 
also taken from the NaOH traps and spent media for determination of cell-labeling efficiency. 
Carotenoid Extraction of Tomato Cells.   
 Labeled and nonlabeled carotenoids were extracted from frozen tomato cells as 
previously described (14) using 0.25-1.0 g cells suspended in 5 mL of ethanol with 0.1% 
butylated hydroxytoluene and homogenization for 20 s using a tissue homogenizer (Kinematic 
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PCU1; Brinkmann, Westbury, NY).  The cells were heated (60 °C) and vortexed every 10 min 
for 30 min.  Samples were then placed on ice, and then 2 mL of HPLC-grade water and 6 mL of 
hexane were added. Samples were then vortexed ~30 s and centrifuged for 10 min at 4 °C to 
separate solvent layers.  The carotenoid-containing hexane phase was removed, and the hexane 
extraction and centrifugation was repeated 2 more times.  Reserved hexane was dried under 
reduced pressure (Speedvac concentrator, model AS160, Savant, Milford, MA) and stored under 
argon at -80 °C for no longer than 48 h before analysis. 
High-Pressure Liquid Chromatography-Photodiode Array (HPLC-PDA) Carotenoid 
Analysis.   
 Samples were analyzed using a HPLC-PDA system and methods for carotenoid separation 
using a C30 reverse-phase column (4.6 " 150 mm, 3 !m, YMC, Wilmington, NC), with mobile 
phases consisting of methanol, methyl-tert butyl ether, and ammonium acetate (12) for the 
quantification and isolation of PE and PF from tomato cell suspension cultures (14).  All 
carotenoids were identified and quantified through a comparison to UV spectra, retention times, 
and standard curves of analytical standards of PE, PF, LYC, BC, LUT (gifts from Hansgeorg 
Ernst, BASF, Ludwigshafen, Germany), "%carotene (ZC), and &-carotene (DC) (Carotenature, 
Lupsingen, Switzerland) with published extinction coefficients (22).  Radiolabeled PE, PF, and 
LYC were first separated using a method developed by Craft (23) on an HPLC-UV/vis Varian 
Prostar dual wavelength detector with Dynamax, SD-200 pumps (Varian, Palo Alto, CA), 
quantified, and collected.  Roughly equivalent amounts of carotenoids (generally between 100 
and 200 ng) were then repurified using the method described earlier using a C30 column and the 
HPLC-PDA system.  Carotenoid fractions were collected according to characteristic retention 
times and quantified on the basis of authentic standards, and solvents were removed under argon.  
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Biosafe II liquid scintillation cocktail (20 mL) (Research Products International Corp., Mount 
Prospect, IL) was first added to the dried carotenoid fractions, held in darkness overnight, and 
analyzed for 14C content using a Beckman liquid scintillation counter, model LS-6500 
(Bakersfield, CA). 
Analysis of 14C Accumulation in Samples and System-Labeling Efficiency.   
 Known amounts of labeled carotenoids, media, or NaOH traps were added to BioSafe II 
(20 mL).  Tomato cells (0.05 g) were solubilized in glass scintillation vials using 1 mL of TS-2 
tissue solubilizer (Research Products International Corp., Mount Prospect, IL) for 6 h at 50 ˚C 
with vigorous mixing by vortex every 30 min to ensure that all cells were dissolved.  This 
mixture was bleached with 1 mL of 30% H2O2 and neutralized with 0.5 mL of glacial acetic acid.  
Samples were held at room temperature for 45 min, and then scintillation cocktail was added. 
The samples were then kept in darkness overnight. 14C content was analyzed by scintillation 
counting the following day.     
Statistical Analysis.   
Treatment group differences were determined using analysis of variance (ANOVA) procedures 
when the assumptions of ANOVA were met, otherwise the Wilcoxon and Kruskal-Wallis 
nonparametric tests were used to evaluate group differences using the statistical analysis 
software SAS v. 7.1 (SAS Institute, Inc., Cary, NC). 
Results 
Herbicide-Induced Carotenoid Accumulation.   
 Herbicide treatments did not affect cell biomass, where the average yield for all cultures 
was 153 ± 11 (standard error of the mean, SEM) g of tomato cells/L (n = 12).  Carotenoid yields, 
however, were enhanced by herbicide treatments.  CPTA alone or in combination with NORF 
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resulted in the greatest total carotenoid (combined LYC, PE, and PF) yields (2.86 and 3.28 mg/L, 
respectively) followed by the NORF treatment alone (2.29 mg/L).  Control cultures had 
substantially lower total carotenoid yield (0.017 mg/L) (Figure 2.2).  When herbicide treatments 
were compared, the combination treatment produced significantly more LYC than the NORF 
treatment (1.24 versus 0.04 mg/L; p= 0.05) and more PE than the CPTA treatment (1.74 vs. 0.14 
mg/L; p=0.05).  CPTA treatment led to significantly greater LYC accumulation (2.49 mg/L) than 
NORF or control treatments (0.04 and 0.04 mg/L; p<0.001 and p=0.02).  NORF caused greater 
PE and PF accumulation (2.06 and 0.18 mg/L, respectively) than control (0 and 0.01 mg/L, 
respectively; p=0.02 and 0.02) and more PE than CPTA treatment (0.14 mg/L; p=0.034) (Figure 
2.2).  The effects of herbicide treatments on other minor, quantified carotenoids (LUT, BC, DC, 
and ZC) are presented in Table 2.1.  
[14C]-Carotenoid Yields from Tomato Cell Cultures Treated with CPTA and NORF.   
 Cultures treated with CPTA (day 1) and NORF (day 7) and dosed with [14C]-sucrose (day 
1) were harvested and weighed after vacuum filtration, and the average mass yield was 151 ± 2 
(SEM) g/L (n = 12).  Upon harvest, samples of culture media, NaOH traps, and system cleanup 
rinse water analyzed by scintillation counting indicated that 52, 17, and 4% of the initial [14C]-
sucrose dose were retained in these system compartments.  A total of 18% of the initial 14C dose 
accumulated in tomato cells and an estimated 0.02% were deposited in combined PE, PF, and 
LYC.  The remaining 9% of the initial [14C]-sucrose was likely distributed throughout all 
experimental compartments (Figure 2.3). The specific activity of the carotenoids analyzed 
ranged from 0.11 to0.22 !Ci/umol (Figure 2.4A).  Phytoene was the most abundant source of 
radiolabeled carotenoid (2.6 nCi/g cells), followed by all-(E)- and 5-(Z)-LYC, other LYC (Z)-
isomers, and PF (2.3, 0.8, and 0.4 nCi/g cells, respectively) (Figure 2.4B).   
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Labeling Efficiency of Cultures Dosed with [14C] Sucrose on Day 1 or Day 7.   
To examine the effect of [14C]-sucrose dose administration timing on carotenoid enrichment, 
labeled sucrose was added to NORF-treated cell cultures on either day 1 or 7 of the 14 day 
growth cycle.  In this trial, cultures dosed on day 1 yielded 167 ± 3 (SEM) g/L (n=6) fresh mass 
and cultures dosed on day 7 averaged 174 ± 2 (SEM) g/L (n = 4).  Dosing on day 1 vs. day 7 led 
to a small increase of 14C content in both PF and PE, causing a 69% and 38% increase in specific 
activities, respectively.  Labeled carbon distribution throughout experimental compartments was 
similar between the two radiolabeling runs (Figure 2.5).  Therefore, despite the slightly higher 
biomass with day 7 dosing, the higher 14C content acquired with day 1 dosing justifies selection 
of day 1 dosing for subsequent work. 
Discussion 
Experiments investigating the effect of CPTA and/or NORF on carotenoid content of tomato 
cell cultures revealed several key points: (a) all herbicide treatments increased total carotenoid 
content; (b) the combination treatment unexpectedly produced LYC even in the presence of 
NORF; (c) unexpected carotenoids were detected; and (d) unique mixtures of carotenoids were 
efficiently produced with each herbicide treatment.  The use of successive CPTA (day 1) and 
NORF (day 7) treatments in a continuous growth cycle allows for the most robust production of 
a useful mixture of carotenoids for subsequent radiolabeling studies.  In contrast, single herbicide 
treatments would be more effective in maximizing the yield of specific [14C]-labeled carotenoids. 
Bleaching herbicides increase total carotenoid content in tomato, pepper, and daffodil plants 
as well as tomato cell cultures (14, 16, 17, 19, 20, 24-26).  The results from the current study 
confirmed either or both herbicides led to a greater total carotenoid yield than untreated cultures 
(135-193-fold).  For NORF treatment, this has been attributed to either an upregulation of the 
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metabolic pathway to compensate for a lack of photoprotective carotenoids or increased 
photostability of carotenoid precursors compared to their downstream products with longer 
polyene chains (24).  The findings from the current report support the first hypothesis but not the 
second.  In the current study, cell culture experiments were carried out in darkness, where 
photostability would not be a contributing factor in carotenoid accumulation.  With regard to 
increased carotenoid accumulation in tomato cultures with CPTA treatment, this may occur 
because of an upregulation of carotenogenesis in response to decreased BC or its derivatives, 
which may normally feedback inhibit upstream carotenogenic enzymes (27).  This hypothesis 
has been supported by increased PSY, PDS, and LCYC mRNA expression and protein levels 
observed in carotenogenic daffodil flowers treated with CPTA (25).   
Second, it was hypothesized that LYC biosynthesis would be blocked in cultures treated with 
CPTA and NORF in combination, causing a substantial elevation of PE and PF accumulation 
compared to NORF alone. The results did not support this hypothesis, showing instead that the 
combined and CPTA treatments alone resulted in similar total major carotenoid content.  
Surprisingly, the combination-treated cells accumulated 37% of the amount of LYC as that found 
with the CPTA alone treatment.  Tomato cell cultures treated with CPTA appear to synthesize 
LYC steadily throughout the growth period (17) thus, the observed LYC was most likely 
produced in the first 7 days of the 14 growth period, while further LYC synthesis was most likely 
halted with NORF treatment on day 7.   
  In addition to detecting PE, PF, and LYC, we detected BC, DC, and LUT in small 
amounts (Table 2.1). This was surprising because CPTA is a LCYC inhibitor; however, the level 
of CPTA provided may have been less than that necessary for complete LCYC inhibition, or 
there may be an alternate pathway for carotenoid cyclization. #-carotene accumulation increased 
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in NORF-treated cells compared to the control, which is also unexpected because NORF is a 
PDS inhibitor (Figure 2.1).  Because PF was present at approximately 1/10 the amount of PE, 
and ZC was present at roughly 1/10 of PF, the chosen NORF dose caused inhibition of PDS, 
although it was incomplete.  
Lastly, different herbicide treatments led to different mixtures of carotenoids.  The combined 
herbicide treatment (NORF + CPTA) led to excellent production of all three tomato carotenoids 
of interest (Figure 2.2).  This novel method of producing carotenoids was thus chosen for 
subsequent radiolabeling studies.  Tailored mixtures, predominant in one or another of the target 
carotenoids, could be encouraged by further alterations of the herbicide treatment. 
The current studies led to several improvements to the previously established carotenoid 
radiolabeling system (14).  Previously, harvest yield obtained from tomato cv. VFNT cherry cell 
cultures was ~ 70 g/L, while the average for the current experiments was nearly double (~ 165 
g/L).  This difference was likely due to adaptation of the cultures over time, in that the tomato 
suspension cultures had been continuously cultured over a period of 12-24 months longer than 
the time of previous experimentation.  Productivity differences between experiments could be 
responsible for the higher carotenoid yields and lower enrichments of the carotenoids, such that 
more 14C was channeled into other biosynthetic pathways than carotenogenesis.  Between the 
two current experiments, different 14C distribution in the experimental compartments was also 
observed, which is likely attributed to later runs accumulating more cell mass (see Figures 3 and 
5).   Contrary to the hypothesis, adding [14C]-sucrose later in the growth period did not 
significantly enhance the specific activity of PE and PF but instead led to lower 14C enrichment.  
It is concluded that tomato cells should be grown with [14C]-sucrose for the full growth period 
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and that the combined CPTA and NORF herbicide treatment induces the production of all three 
major tomato carotenoids.  
The methods described here for increasing total carotenoid yield, improving carotenoid 
profiles, and increasing carotenoid specific activity, along with a recently improved tomato cell 
extraction protocol (28), enhance the efficient production of radiolabeled carotenoids.  In 
addition, these results demonstrate that changing herbicide treatments can alter carotenoid 
profiles.  For example, lowering the NORF dose could potentially reduce efficiency of PDS 
inhibition and allow for a greater accumulation of PF.  One future direction of interest would be 
to use a high LYC-producing tomato cell line to further increase overall carotenoid-producing 
potential.  The methods described here could also be used to produce stable isotope-labeled 
tracers for human metabolic research, using [13C]-glucose as the primary carbon source for the 
cultures.  
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Figure 2.1.  Tomato carotenoid biosynthetic pathway. 
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Figure 2.2.  Effects of herbicide treatments on production of three carotenoids from tomato cv. 
VFNT cherry cell culture grown for 14-d.  See the Materials and Method section for details of 
treatments.  Bars with different letters are significantly different according to Kruskal-Wallis test 
($= 0.05).  Error bars represent SEM for combined PE, PF, and LYC (n = 3 trials, analyzed 3 
flasks/trial in duplicate). 
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Figure 2.3. 
 
Figure 2.3. Percent recovery of 14C provided on day 1 of a 14-d growth period to tomato cell 
cultures treated with CPTA on day 1 and NORF on day 7. 
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A. 
 
B. 
Figure 2.4.  (A) Carotenoid specific activity and (B) radioactivity yield of carotenoids from 
CPTA- and NORF-treated cell cultures.  [14C]-Sucrose was provided on day 1 of a 14 day growth 
period. Error bars represent standard error of the mean. n = 3 culture flasks analyzed in duplicate 
for each carotenoid. 
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Figure 2.5. Carotenoid specific activity (A) and 14C distribution in compartments of cultures 
treated with [14C]-sucrose on day 1 (full growth period) (B) or day 7 of the growth period (day 7-
14) (C). 
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Table 2.1.  Yield of minor carotenoids following herbicide treatment of tomato cv. VFNT 
cherry cell cultures after a 14-d growth period.  Data are averages of 2 trials, each 
analyzing 3 flasks, in duplicate. 
  (ug/L) 
Treatment !-carotene "-carotene Lutein #-carotene 
 Control 16.3 0.709 16.6 0.00 
 CPTA 9.17 1.12 7.53 0.00 
 NORF 7.64 20.7 13.5 10.2 
 NORF and 
CPTA 7.17 26.8 10.1 1.64 
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CHAPTER 3: 
Screening and Selection of High Carotenoid Producing in Vitro Tomato Cell Culture Lines 
for [13C]-Carotenoid Production34 
Abstract 
Isotopically labeled tomato carotenoids, phytoene, phytofluene, and lycopene, are needed for 
mammalian bioavailability and metabolism research but are currently commercially unavailable.  
The goals of this work were to establish and screen multiple in vitro tomato cell lines for 
carotenoid production, test the best producers with or without the bleaching herbicides, 
norflurazon and 2-(4-chlorophenyl-thio)triethylamine (CPTA), and to use the greatest carotenoid 
accumulator for in vitro 13C-labeling.  Different Solanum lycopersicum allelic variants for high 
lycopene and varying herbicide treatments were compared for carotenoid accumulation in callus 
and suspension culture, and the hp-1 cell suspension culture system was chosen for isotopic 
labeling.  When grown with [U]-13C-glucose and treated with CPTA, hp-1 suspensions yielded 
highly enriched 13C-lycopene with 45% lycopene in the M+40 form and 88% in the M+35 to 
M+40 isotopomer range.  To the authors' knowledge this is the first report of highly enriched 
13C-carotenoid production from in vitro plant cell culture. 
Introduction   
 Frequent tomato consumption is believed to contribute to a balanced diet as well as 
reduce chronic disease risk, most notably prostate cancer and cardiovascular disease (1).  
Tomatoes are a rich source of vitamins and minerals, as well as pro-vitamin A and nonpro-
                                                
3 This chapter was the result of a collaboration of the following authors: Nancy J. Engelmann, 
Jessica K. Campbell, Randy B. Rogers, S. Indumathie Rupassara, Peter J. Garlick, Mary Ann 
Lila, and John W. Erdman, Jr. 
4 Reproduced with permission from: Engelmann, N.J.; Campbell, J.K.; Rogers, R.B.; Rupassara, 
S.I.; Garlick, P.J.; Lila, M.A.; Erdman, J.W., Jr. Screening and selection of high carotenoid 
producing in vitro tomato cell culture lines for [(13)C]-carotenoid production. J. Agric. Food 
Chem. 2010, 58, 9979-9987. Copyright 2010. 
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vitamin A carotenoids.  Carotenoids are lipophilic tetraterpenes with conjugated double bonds, 
which are responsible for the bright orange, yellow, and red colors seen in nature (2).  Raw, red 
tomatoes contain substantial amounts of the red carotenoid lycopene (LYC), the colorless 
carotenoids phytoene (PE) and phytofluene (PF) (9270, 1860, and 820 µg/100 g, respectively), 
and smaller amounts of cyclic carotenoids and xanthophylls such as #-carotene and lutein (230 
and 80 µg/100 g, respectively) (3), although these concentrations can vary substantially by 
ripeness and cultivar.   
 The health protective effects of tomatoes are widely believed to be due to carotenoid 
bioactivity; however, the exact mechanisms responsible are debatable (1, 4).  An array of LYC 
metabolic and oxidative products have been detected in both tomato-based foods and human 
serum, but it remains unclear whether these products are endogenously produced or absorbed 
from the food products (5).  PE and PF are absorbed from foods and are present in human plasma 
after 4-weeks of tomato juice consumption (6) and also show different bioaccumulation patterns 
than LYC in rats in response to a 4 wk tomato powder feeding regimen (7).   The overarching 
questions regarding carotenoid bioactivity are (A) are intact carotenoids or metabolic and/or 
oxidative products of these carotenoids bioactive? (B) Is LYC solely responsible for bioactivity, 
or are the other colorless carotenoids, PE and PF, also bioactive?  In order to answer these 
questions, biolabeled carotenoids are necessary for animal and human feeding studies to trace the 
differential absorption and metabolism of these prominent tomato carotenoids.   
 Plant cell culture is an efficient tool for producing labeled plant secondary metabolites.  
In vitro plant methodologies allow for rigorously controlled growing conditions, reliable 
biochemical responses, short-growth periods, targeted production of desired phytochemicals, 
simplified extraction, and directed utilization of costly isotopically labeled carbohydrates (8).  In 
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particular, this approach is well suited for labeling secondary metabolites that are found in only 
plant fruit tissues such as tomatoes and berries, where whole plant labeling via enriched water or 
carbon dioxide would be wasteful and time consuming.  Whole plant, or intrinsic, labeling, on 
the other hand, is well suited for plants that can be grown quickly, and the entire plant can be 
used as a source of the desired phytochemical (for an example of intrinsic labeling, see ref 9).  
Previously, tomato carotenoids, red clover and kudzu isoflavones, and grape and berry 
polyphenols have been successfully radiolabeled (i.e. 14C) using in vitro plant cell cultures for 
utilization in animal phytochemical metabolism research (8, 10-14), and grape flavonoids have 
been 13C-labeled (15, 16). However, this technology, to the authors' knowledge, has not yet been 
applied to the production of 13C-labeled carotenoids for mammalian metabolic research.   
 Two general approaches exist for the efficient production of secondary metabolites from 
plant cell cultures.  First, plants known to hyper-produce a desired phytochemical can be used to 
derive an in vitro cell line, and that cell line can be evaluated for its phytochemical production 
profile.  Second, elicitors or enzyme modulators can be used to induce or enhance secondary 
metabolite production and accumulation in in vitro cultures (17).  LYC, PE, and PF 
accumulation in tomato cell culture can be enhanced by treating with the bleaching herbicides 
norflurazon and/or 2-(4-chlorophenyl-thio)triethylamine (CPTA) (10, 11).   Norflurazon inhibits 
phytoene desaturase, leading to an accumulation of PE and PF, while CPTA inhibits lycopene 
cyclase, leading to an increase in LYC accumulation (10).   
 The goal of the following work was to establish tomato cell lines for the efficient 
production of 13C-carotenoids found in tomato fruit for nutritional research.  A screening 
program was implemented to identify high LYC and high PE and PF accumulating cell lines then 
their carotenoid production in response to herbicide treatments tested (Figures 1A and B).  The 
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ghost (gh) phenotype tomato was used to derive plant cell cultures to investigate their potential 
to produce PE and PF (Figure 3.1A).  The gh plant is deficient in plastid terminal oxidase 
(PTOX), which is a plastoquinone-O2 oxidoreductase that likely serves as a necessary cofactor 
for carotenoid dehydrogenases.  The lack of PTOX, therefore, interrupts efficient 
carotenogenesis (18).  There are nine genetic loci known within tomatoes that control fruit 
pigmentation; therefore, several putative high LYC producing tomatoes were selected to be 
scanned for in vitro LYC production. Solanum lycopersicum plants carrying hp-1, hp-2^dg, B^og 
and B^ogc alleles in these loci previously reported to have enhanced LYC accumulation were 
scanned and compared to the previously established VFNT cherry tomato cell line, a line used 
for the production of radiolabeled carotenoids and in vitro carotenogenesis studies (10, 11, 19).  
An additional wild species of tomato, Solanum pimpinellifolium, was also selected for its 
elevated LYC accumulation (19). The best performing high LYC cell line was then grown with 
[U]-13C-glucose to produce 13C-LYC, which was purified and analyzed for isotopic enrichment 
(Figure 3.1B). 
Materials and Methods 
Ghost Plant Material and Culture Initiation 
Seeds from gh/+ tomato (Solanum lycopersicum cv. Mill, donated by Wendy White) were 
germinated under very low light (9 µE m-1s-1), and after 5 days, low irradiance was maintained 
(~80 µE m-1s-1) to allow for viable variegated gh (gh/gh) seedlings since higher light intensities 
cause a lethal white-leafed phenotype (20).  The seedling genotype was identified by the 
presence of either purple shoots and variegated or white leaves (gh/gh; gh), or green leaves (+/+ 
or gh/+; wild-type)  (20).  Stem and leaf segments were collected at 4 weeks, and flower buds at 
11 weeks from greenhouse-grown plants for disinfestation by dipping in 70% aqueous ethanol, 
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immersing in 7.5% sodium hypochlorite with one drop of Tween-20 (Sigma-Aldrich, St. Louis, 
MO) for 15 min, and rinsing with sterile distilled water for 5 min.  Explants were placed onto 40 
mL of sterile, agar-solidified Murashige and Skoog salt-based media containing the growth 
regulators 2,4-dichlorophenoxyacetic acid and 6-benzylaminopurine (maintenance media) for 
tomato callus induction as previously described (11) in GA-7 cubes (Magenta Corporation, 
Chicago, Illinois).  During callus induction, gh stem and leaf-derived calluses were transferred to 
fresh solidified media after 35 days, then subsequently every 21 days. To promote healthy callus 
growth, gh flower bud-derived callus was transferred to fresh solidified media after 23 days, 12 
days later, 9 days later, and subsequently every 21 days.  Leaf segments and flower buds from 
wild-type plants were transferred to fresh solidified media after 41 days and subsequently every 
21 days. Cell suspension cultures were initiated with 2 g of friable and the callus added to the 
same callus induction media as mentioned above, formulated without agar.  Cell suspension 
cultures were subcultured every 2 weeks by the transfer of 6 mL aliquots of established cultures 
(2 mL of packed cells with 4 mL ofspent media) to fresh maintenance media.  
Carotenoid Evaluation of Different Ghost Genotypes in Callus and Cell Suspension 
Cultures.  
 For carotenoid analysis, proliferating gh and wild-type callus cultures were initiated with 
2 g callus/40 mL of solid maintenance media in GA-7 cubes (n = 4-6) and were harvested after 3 
weeks.   Harvested samples were stored at -80 ˚C until carotenoid extraction and HPLC analysis.  
Carotenoid yield was evaluated for gh cell suspension cultures grown in either liquid 
maintenance media or the previously described carotenoid production media containing the 
growth regulators indole-3-acetic acid (5 mg/L) and all-trans-zeatin (2 mg/L) (11).  Suspension 
cultures were continuously maintained at 2 week subculture intervals by inoculating either 40 
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mL of maintenance media in 125 mL flasks with 6 mL of established cultures or 80 mL of 
carotenoid production medium in 250 mL flasks inoculated with 12 mL of established cultures (4 
mL of packed cells and 8 mL of spent media) and were grown (n = 5/media formulation) for one 
2 week growth period and then harvested.        
High LYC Cell Line Plant Material and Culture Initiation 
 Seeds of Solanum pimpinellifolium (LA0376) and Solanum lycopersicum cultivars ['Ailsa 
Craig' hp-1 (LA3538), 'Manapal' hp-2^dg (LA2451), 'Ailsa Craig' B^og (LA3311), wild-type 
'Ailsa Craig' (LA2838A), and wild-type 'Manapal' (LA3007)] were obtained from the Tomato 
Genetics Research Center, UC-Davis, CA, USA.  Solanum lycopersicum  'Suncoast' B^ogc seeds 
were obtained as a gift from Jay Scott and 'VFNT cherry' seeds from Betty Ishida.  Germinated 
seeds were allowed to reach maturity in a greenhouse.  Flower buds and leaves were used to 
generate callus cultures as described above.  Callus was subcultured every 4 weeks for at least 2 
growth cycles until friable calluses developed.  Transfer of 2 g of callus to 40 mL of maintenance 
media initiated liquid suspension cultures.  Cell suspensions were subcultured every 2 weeks as 
described above. 
Herbicide Treatment Experiments 
 Cultures were either treated aseptically on day 1 with filter-sterilized aqueous CPTA 
(donated by Betty K. Ishida, USDA ARS, St. Albany, CA) (0.0745 g/L media) (10) and/or on 
day 7 with filter-sterilized norflurazon (Syngenta, Greensboro, NC) dissolved in dimethyl 
sulfoxide (0.06 mg/80 mL media) as previously published (11).  To investigate the potential for 
increasing carotenoid accumulation in gh and wild-type cell suspension cultures, either 
norflurazon or CPTA was added to gh and wild-type cultures. Herbicides were provided to gh 
and wild-type cell suspension cultures in 80 mL of the carotenoid production medium.  High 
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LYC tomato cell lines were also treated with CPTA to stimulate LYC accumulation either by 
aseptic addition to freshly autoclaved callus carotenoid production media before solidification or 
to cell suspension cultures in liquid carotenoid production media.  Callus cultures were grown 
with or without CPTA in the solid media for one 4 week growth cycle and suspensions for 2 
weeks.  The hp-1 tomato cell line was treated with CPTA and/or norflurazon, as specified, to 
investigate the potential to manipulate the carotenoid accumulation profile.   
Callus and Cell Suspension Culture Harvest 
 Callus cultures were harvested by careful separation of the callus from solid media using 
metal spatulas and weighed, and fresh mass was recorded.  Labeled and nonlabeled cell 
suspension cultures were harvested using Whatman #4 filters with a Büchner funnel over a 
vacuum.  Filtration was ended, and cells were collected and weighed when no liquid was 
expressed from the funnel for 30 s.  All collected culture samples were stored under argon in 
containers, capped, sealed with Parafilm, and stored at –80 ˚C until further analysis. Samples (~5 
g) of each 13C labeled culture were reserved for further carotenoid and 13C mass spectrometry 
analysis, and the remaining cells were combined for carotenoid extraction and preparatory 
separation for future mammalian metabolic studies.  
HPLC Carotenoid Evaluation 
 Callus and suspension cultures were analyzed for carotenoid content by extracting ~0.25 
g of cells using a carotenoid extraction and high pressure liquid chromatography-photodiode 
array (HPLC-PDA) analysis protocol previously published (11).  General precautions for work 
with carotenoids were taken to prevent degradation and artifact formation during the extraction 
and analytical process (21).  Carotenoids were identified and quantified by external standard 
curves using authentic LYC (isolated from DSM Redivivo Beadlets donated by DSM, Heerlen, 
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Netherlands), and PE and PF standards (gifts from Hansgeorg Ernst, BASF, Ludwigshafen, 
Germany).   
Selection of the Highest LYC Accumulating Cell Line 
 Callus cultures of mutant high LYC lines, corresponding wild-type cell lines, and the 
'VFNT cherry' cell line were evaluated for LYC accumulation during 3 trials with 2 reps per trial.  
Each rep consisted of 3 g of callus inoculum placed onto agar-solidified carotenoid production 
medium with or without CPTA.  Mutant high LYC line CPTA-treated cultures were compared to 
corresponding CPTA-treated wild-type lines to verify that the mutation was responsible for LYC 
accumulation differences.  The highest LYC accumulators and available corresponding wild-type 
callus cell lines were then used to initiate cell suspension cultures by transferring 2 g of friable 
callus cultures to liquid maintenance medium.  After 8.5, 10.5, and 11 months of culture 
adaptation to liquid medium, cultures were transferred to carotenoid production medium for one 
2-week adaptation period and subsequently transferred to fresh carotenoid production medium 
with or without CPTA for a 2-week carotenoid production growth period, and then harvested for 
subsequent analysis.  
Comparison of hp-1 Carotenoid Production Grown with Sucrose or Glucose As the 
Carbohydrate Source. 
 Presently, the only economical [U]-13C labeled carbohydrate for addition to cell culture 
media is glucose; however, standard tomato growth media utilizes sucrose.  To determine the 
effect of medium carbohydrate source on harvest mass yield and carotenoid concentration, hp-1 
cell suspension cultures were grown in liquid carotenoid production media with either 30 g/L 
unlabeled sucrose or unlabeled glucose for a single, 14-day adaptation growth cycle, transferred 
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to fresh media, and treated with CPTA as specified above for a 14-day growth cycle, then 
harvested for analysis. 
Production of 13C-labeled LYC from hp-1 Tomato Cell Suspension Cultures 
 For LYC 13C-biolabeling, 2 flasks of 80 mL liquid carotenoid production medium 
containing 30 g/L unlabeled glucose were inoculated with established cell suspension cultures 
for a media adaptation growth cycle.  The contents of these two flasks were combined aseptically 
and 12 mL aliquots of the established cultures (4 mL of packed cells with 8 mL of spent media) 
were used to inoculate 3 flasks of fresh medium with 30 g/L [U]-13C-glucose (Cambridge Isotope 
Laboratories, Inc., Andover, MA).  The established cultures grown for the glucose adaptation 
growth cycle utilize glucose as an energy source, therefore it can be estimated that the resultant 
13C-glucose/12C-glucose ratio in the fresh 13C-containing media is greater than 10:1.  Other 12C-
containing components in the media such as growth regulators and myoinositol accounting for 
less than 1% of the organic content in the media are likely minor contributors to carotenoid 
precursors.  Cultures were grown in a previously described enclosed labeling chamber at 26 ˚C 
atop a rotary shaker (160 rpm) (22).  To promote LYC accumulation, cultures were treated with 
CPTA on day 1, grown for 14 days, harvested, and stored for carotenoid and isotope enrichment 
analysis.   
13C-Carotenoid Mass Isotopomer Analysis 
 Biolabeled carotenoids were isolated from hp-1 cell suspension cultures by a series of 
three HPLC separations.  First, a previously optimized carotenoid extraction procedure for 
tomato cell suspension cultures was utilized (23).  Carotenoid-rich extracts were first 
subfractionated to yield an LYC-rich fraction using a YMC C30 preparatory column (Waters, 
Milford, MA) with previously described conditions (11).  Mobile phases in the carotenoid 
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containing eluate fractions were evaporated using a Savant AS160 Automatic Speedvac.  This 
fraction was subfractionated a second time to remove coeluting contaminants using a Discovery 
C18 (25 cm x 4.6 mm, 5 µm) (Supelco, Sigma-Aldrich, St. Louis, MO) column following a 
previously published method (24).   Eluted LYC was collected, and one third and final separation 
was performed on the same HPLC apparatus described using a high resolution HPLC method 
using a YMC C30 analytical column (4.6 x 25 cm, 3 µm) to obtain pure all-E LYC containing 
minimal coeluting carotenoids or contaminants (25).  LYC from this purified fraction was then 
analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) using 
atmospheric pressure chemical ionization (APCI) at 2877 V, 400 °C, a nebulizer pressure of 60 
psi, and dry temperature of 350 °C.  Purified 13C-LYC  was dissolved in diethyl ether and 
injected onto a LC-MS/MS (LC-MSD-Trap-XCT plus, Agilent Technologies, Santa Clara, CA) 
equipped with a Zorbax Eclipse XDB C18 column (Agilent Technologies, Santa Clara, CA; 2.1 
x 50 mm, 3.5 µm).  Sensitivity of the LC-MS/MS used was 1-10 ng, and higher amounts were 
injected to facilitate the quantification needed for mass isotopomer analysis.  To quantify the 
proportions of different isotopomers present in the 13C-LYC peak, four injections of 1000 ng of 
13C-LYC in 40 mL of diethyl ether were made, and data acquisition parameters were set to 
collect signal intensities for LYC masses on positive ion mode ranging from m/z 572.4-577.4 (M 
+ 35 to M + 40) for injection 1, m/z 567.4-572.4 (M + 30 to M + 35) for injection 2, m/z 562.4-
567.4 for injection 3 (M + 25 to M + 30), and m/z 557.4-562.4 for injection 4 (M + 20 to M + 
25).  Mass chromatogram peak areas generated from the resulting runs were normalized on the 
basis of repeated m/z channels analyzed between runs and were then quantified. Mass 
chromatogram peak areas for masses below 557.4 were not quantifiable; therefore, the effective 
range of masses evaluated was from m/z 557.4-577.4 (M+20 to M+40). Relative signal 
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intensities for carotenoid mass isotopomers were compared, and the 13C-enrichment profile was 
quantitatively determined using spectral peak areas. 
Statistical Analysis 
Statistically significant treatment and cell line differences for >2 groups were determined by 
analysis of variance (ANOVA), and when the normality and homogeneity of variance 
assumptions of ANOVA were met, the posthoc Tukey's studentized range test was used to 
identify specific differences. When the assumptions of ANOVA were not met, the nonparametric 
Wilcoxon and Kruskal-Wallis tests were used to detect significant differences.  When only two 
treatments were being compared, the two-sample t test was used, and when the normality and 
homogeneity of variance assumptions of the t test were met, the equal variances t test was used 
to determine significant differences.  If both the normality and homogeneity of variance 
assumptions of the two-sample t test were not met, the Wilcoxon two-sample test was used.  If 
only the homogeneity of variance assumption of the two-sample t test was violated, then 
Cochran modified t test for unequal group variance was used.  All statistical analyses were 
performed using the statistical analysis software SAS, versions 7.1 and 9.2 (SAS Institute, Inc., 
Cary, NC). Averages are presented with the standard error of the mean whenever possible. 
Results and Discussion 
1. gh and Wild-Type Tomato Cell Cultures 
1.1 Callus and Suspension Culture Initiation. 
 Eighty-percent of the seeds from wild-type (+/+ or +/gh) tomato germinated within 9 days 
and of those, 10% were positively identified as gh mutants by the presence of variegated true 
leaves.  Callus growth was observed within 16 days on the surface of the gh stem and leaf 
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explants and within 30 days on gh flower bud explants.  Callus growth on wild-type explants was 
observed within 41 days on leaves and within 20 days on flower buds.   
1.2 Carotenoid Accumulation by Genotype and Explant Source. 
 Wild-type and gh callus cultures were sampled and analyzed for carotenoid 
concentrations.  The gh flower bud-derived callus culture accumulated the greatest amount of 
total carotenoids with PE being the major carotenoid (5.6 ± 1.8 µg/g callus) and PF, LYC, and 
#%carotene (Table 3.1) in lower concentrations.  Both leaf and flower bud-derived gh callus 
cultures had greater overall carotenoid accumulation than the wild-type callus cultures, though 
the wild-type-derived callus cultures had greater #-carotene concentrations than the gh callus 
cultures.  The phenomenon where one in vitro vegetative tissue differs biochemically from 
another has been seen before (26).  Previous studies of in vitro 'VFNT cherry' tomato sepals, the 
vegetative tissue that forms a protective layer around the flower, indicated that this tissue has the 
potential to undergo ripening processes including LYC accumulation, swelling, and production 
of ethylene and its precursor, without manipulation of the media growth regulators or attachment 
to fruit.  The results in this article support the finding that sepal tissue of the flower bud may 
retain a potential to change the developmental fate from vegetative tissue to fruit-like tissue, 
allowing ripening processes, which include increased carotenogenesis (26).  In that same study, it 
was observed that another tomato cultivar, 'Ailsa Craig', did not exhibit the same sepal ripening 
process, suggesting that the involvement of a genetic component for this retained the ripening 
potential in sepal tissue (26).  In vitro explant-specific secondary metabolite profiles from callus 
cultures of red clover for isoflavones and of strawberry for anthocyanins have also previously 
been observed (12, 27).  Flower bud-derived gh callus exhibits more ripening processes than 
leaf-derived calluses, however, the wild-type callus types did not show this same trend, 
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suggesting that there may be a genotype effect on carotenoid accumulation in differentially 
derived callus tissues.   
1.3 Treatment with Herbicides. 
 A brief investigation on the impact of CPTA and norflurazon on carotenoid accumulation 
in gh and wild-type cell suspension cultures grown in carotenoid production media (one 
trial/herbicide treatment, n = 2-3 reps/treatment) showed that the gh cell line yielded greater 
harvest mass than the wild-type cell line, regardless of herbicide treatment.  In the CPTA and 
norflurazon experiments, gh cell suspension cultures yielded almost 3 times more cell mass than 
wild-type cultures (363 vs 95 and 347 vs 90 g cells/L culture, respectively). Counter to the initial 
hypotheses for this study, neither of the herbicides had a substantial impact on PE or PF 
accumulation in gh cultures; however, herbicide treatments did impact carotenoid accumulation 
profiles in wild-type cell suspension cultures (Tables 2 and 3).   These results suggest that these 
bleaching herbicides may cause greater total carotenoid accumulation in wild-type cultures by 
causing a lack of downstream carotenoid products necessary for feedback regulation of 
carotenogenesis.  Since the gh cell line already largely lacks downstream carotenoids, the 
bleaching herbicides did not confer any additional stimulation of PSY or inhibition of PDS. In a 
previous study, mRNA levels of carotenogenic enzymes in gh tomato fruit were similar to the 
levels in wild-type fruit, suggesting that a lack of downstream carotenoid products may not 
increase the transcription of these enzymes (20). It may be possible that the activity of the PSY 
enzyme is increased in the gh cell line compared to that in the wild-type cell line. CPTA-treated 
wild-type cultures did have increased LYC accumulation compared to that in the control wild-
type and CPTA-treated or control gh cultures (Table 3.2).  Norflurazon-treated wild-type 
cultures, however, did not produce as much PE as the gh cultures (Table 3.3). On the basis of 
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these results indicating that untreated gh cell suspension cultures accumulate and yield the 
greatest amount of PE, herbicide treatment of the gh cell line was not pursued further.  All 
additional gh experiments focused on the untreated gh cell line. 
1.4 Comparison of gh Carotenoid Production from Cultures Grown in Different Media 
Formulations. 
Three trials were performed to evaluate gh cell suspension culture carotenoid production and cell 
mass accumulation from cultures grown in carotenoid production versus maintenance medium.  
Cultures grown in the carotenoid production media produced significantly greater cell mass (211 
± 7.2 g/L) than the maintenance media-grown cultures (150 ± 4.1 g/L) (p=0.0017). PE yield was 
also greater in carotenoid production media (3458 ± 612 µg/L) than from maintenance media 
(489 ± 84 µg/L; p = 0.04).  On the other hand, PF yield was not significantly different between 
media conditions (maintenance media: 27.8 ± 2.2 µg/L; carotenoid production media: 78.7 ± 
16.8 µg/L; p = 0.09).  This experiment confirmed the hypothesis that carotenoid accumulation 
would be greater in cultures grown on the carotenoid production media formulation.    The PE 
yield from gh cultures grown on carotenoid production media is greater than that of ‘VFNT 
cherry’ tomato cell suspension cultures treated with norflurazon (2060 µg/L), a previously 
established suspension culture system for PE production (10).  On the basis of these findings, it 
can be concluded that gh cell suspension cultures are a superior source of PE.   
 2. High LYC Lines 
2.1 Callus Culture Initiation. 
 Tomato flower buds from greenhouse-grown high LYC tomato plants and their 
corresponding wild-type plants were explanted to agar-solidified callus induction media.  Callus 
was observed on all explants within a 1-4 wk growth period, and proliferating, friable callus was 
 65 
obtained within 2-3 growth cycles of the 'Ailsa Craig' wild-type and hp-1, 'Manapal' wild-type 
and hp-2dg, 'Suncoast' B^ogc, L. pimpinellifolium, and 'VFNT cherry'. 'Ailsa Craig' B^og did not 
adapt well to the callus induction media and was not included in subsequent studies. 
2.2 Selection of Highest LYC Accumulator 
 Three trials examining several high LYC lines, corresponding wild-type lines, and the 
'VFNT cherry' line callus cultures for LYC accumulation were harvested and analyzed.  Harvest 
yields of CPTA and untreated 'VFNT cherry' callus cultures were significantly greater than those 
in other CPTA or untreated cultures, respectively (Table 3.4).  Carotenoid concentrations were 
greatly increased when CPTA was added to the agar-solidified carotenoid production medium 
(Table 3.5).  In untreated cultures, there was no cultivar or genotype effect on combined PE, PF, 
#-carotene, and LYC accumulation.  Alternatively, when CPTA was present in the media the hp-
1 cell line had a significantly greater combined acyclic carotenoid (PE, PF, and LYC) 
concentration (45.8 ± 13.1 µg/g cells) than the other cell lines including its corresponding wild-
type (27.2 ± 4.5 µg/g cells), suggesting that the hp-1 genotype is responsible for the enhanced 
carotenoid accumulation.  All cell cultures treated with CPTA had only trace amounts of #-
carotene (data not shown).  The two highest carotenoid accumulators, 'Ailsa Craig' hp-1 and 
'Manapal' hp-2 (45.8 ± 13.1 and 31.3 ± 7.1 µg/g cells, respectively), in callus culture were thus 
selected along with their corresponding wild-types to be transferred to solution culture and 
evaluated for LYC production in comparison to previously established 'VFNT cherry' cell 
suspension cultures.  
 Three trials were initially performed to evaluate 'Ailsa Craig' hp-1 and wild-type, 
'Manapal' hp-2 and wild-type, and 'VFNT cherry' cell suspension cultures for LYC production. 
Over the period of the three trials, substantial changes in LYC concentration and yield were 
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observed (Figure 3.2 A & B).  Some tomato cell lines adapted to the carotenoid production liquid 
medium, while other cell lines performed more poorly over the 2.5-month span in which the 
three trials were undertaken. The changes in harvest mass and LYC concentrations over the 2.5-
month trial period were substantial, but this is common during the establishment of in vitro plant 
cell lines.  Bourgaud and colleagues discussed this phenomenon in callus cultures previously, 
suggesting that in many cases erratic production of plant secondary metabolites in vitro can be 
linked to genetic instability (17).  Genetic instability, according to their assessment, is often 
under-reported in publications but has been observed to take up to 16 subculture cycles, or 48 
wk, to dissipate.  One practical suggestion given by these authors was to use cell growth 
reproducibility, a polygenic characteristic, over three consecutive growth cycles as a marker for 
genetic stability (17).  Although these authors discussed the appearance of this phenomenon in 
callus cultures, from the current studies, it appears that genetic instability is apparent in cell 
suspension cultures and that adaptation time can be lengthy.  For this reason, tomato cell line 
selection was based on LYC yields obtained from the final trial completed 11 months postcell 
suspension culture initiation.  Eleven months postinitiation of cell suspension cultures, 'Ailsa 
Craig' hp-1 yielded the greatest amount of LYC (7.58 mg/L culture) and was 1.6-fold greater 
than the 'VFNT cherry' LYC yield (2.97 mg/L culture) followed by 'Ailsa Craig' wild-type (5.47 
mg/L culture) (Figure 3.2B).  'VFNT cherry' cell suspension cultures produced the highest 
concentrations of PE with CPTA-treatment (5.22 µg/g cells) and were also the greatest 
accumulators of PE when untreated (0.70 µg/g cells), compared to the other cell lines (Table 
3.6).  'Ailsa Craig' hp-1 also yielded the greatest cell mass (199 g/L) at the 11-month harvest.  
The high cell mass production combined with high concentrations of LYC led to the selection of 
the 'Ailsa Craig' hp-1 for subsequent herbicide treatment and 13C-biolabeling studies.  To 
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ascertain genetic stability, the three subsequent herbicide trials were run consecutively, per the 
recommendations of Bourgaud et al. (17). 
2.3 Treatment with Herbicides 
 Three consecutive trials with three repetitions per trial were harvested to simultaneously 
evaluate the genetic stability of and carotenoid accumulation in hp-1 cell suspension cultures in 
response to different herbicide treatments.  Within the control, CPTA, and norflurazon 
treatments, there were no significant harvest mass yield differences between trials according to 
the Kruskal-Wallis test (average yields were 218 ± 42 g/L, 156 ± 16 g/L, and 220 ± 40 g/L, 
respectively).  However, there was a significant difference within the CPTA and norflurazon 
combination treatment group between trials  ($ = 0.05) between the first (214 ± 33 g/L) and third 
(119 ± 3 g/L) trials, but neither was different from the second trial (183 ± 3 g/L) according to 
Tukey's studentized range test.  Although there were differences between the harvest yields of 
the CPTA and norflurazon combination treatment between trials, the remainder of the treatments 
had statistically consistent harvest yields and can be viewed, on the whole, as genetically stable.  
When harvest yields were compared between treatments for all trials, there were no significant 
differences, including the CPTA and norflurazon combination treatment (average 172 ± 28 g/L; 
other treatment averages given above). Carotenoid yields were analyzed for each trial (Figure 
3.3).  There were no significant differences in individual carotenoid concentrations by herbicide 
treatment; however, total carotenoid yields in herbicide-treated cultures were significantly 
greater than the control cultures ($ = 0.05) (Figure 3.3).  The PE, PF, and LYC accumulation 
patterns were similar to, but overall greater than, the accumulation pattern previously seen in 
'VFNT cherry' tomato cell suspension cultures treated with these herbicides (10) (3.6 - 5.2 mg/L 
culture vs 2.3-3.3 mg/L culture, respectively) (10).  This result suggests that hp-1 tomato cell 
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suspension culture is superior to the previously established 'VFNT cherry' cell suspension culture 
system.  The untreated gh tomato cell line, when grown on carotenoid production media, also 
produced substantially more PE than previously published values for the norflurazon-treated 
'VFNT cherry' line, but had a lesser PE accumulation than the norflurazon-treated hp-1 cell line.  
On the basis of these findings, the hp-1 cell line treated with CPTA was selected for 13C-LYC 
labeling. 
3. Tomato Cell Suspension Culture 13C-Carotenoid Biolabeling 
3.1 Comparison of Carotenoid Production in hp-1 Cell Suspension Cultures Grown with 
Sucrose or Glucose as the Carbohydrate Source. 
 Carbohydrate source in the tomato cell culture liquid media did not have a significant 
impact on harvest mass yield (glucose, 199 ± 19 g/L; sucrose, 206 ± 2 g/L).  Neither total 
carotenoid yield (glucose, 6.22 ± 0.34 mg/L; sucrose, 5.81 ± 1.17 mg/L) nor individual 
carotenoid proportions significantly varied by carbohydrate source (data not shown).   
3.2 13C-labeled carotenoid yields from hp-1 cell cultures. 
 Harvest mass yields for hp-1 cell cultures grown with uniformly labeled 13C-glucose as 
the primary carbon source (198 ± 3.6 g/L) were very similar to yields from cultures grown with 
unlabeled glucose.  Carotenoid yields were, however, slightly lower than those seen in the 
herbicide and carbohydrate source experiments (PE, 0.313 ± 0.013; PF, 0.12 ± 0.01; LYC, 2.45 ± 
0.11).  After three HPLC purification steps of the plant cell culture carotenoid extract, purified 
LYC was obtained (Figure 3.4).  LYC was analyzed and purified for mass isotopomer analysis, 
and the results are shown in Figure 3.5.  In vitro labeling does not yield 100% uniformly labeled 
LYC but rather a range of isotopomers (m/z=557-577), which represent the M + 20 to + 40 
isotopomer masses.  The uniformly labeled isotopomer (m/z=
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prominent isotopomer constituent (45%) of the labeled LYC fraction, and 88% of the LYC 
molecules were present as M + 35 to + 40 masses.  Production of a distribution of  #-carotene 
and LYC mass isotopomers has been previously reported in other biological systems (28-30).  
By providing uniformly labeled glucose as the primary source of carbon in this in vitro system, 
the labeled LYC produced from this experiment had a much greater proportion of uniformly 
labeled (m/z = 577) LYC than what has been seen in these other reports of deuterium enriched #-
carotene and LYC.  In this experiment, the unenriched isotopomer (m/z = 537) was not detected 
in purified 13C-LYC isolated from hp-1 cell cultures.     In conclusion, a strategic screening and 
selection process for carotenoid accumulation in multiple in vitro tomato cell lines noted for their 
elevated in vivo carotenoid accumulation was used to develop a production system for 
isotopically labeled carotenoids for utilization in human and animal metabolic tracing studies.   
To the authors' knowledge, this is the first report of the production of highly enriched 13C-
carotenoids from a plant cell culture system for dietary research. 
 Future work should focus on stimulating PF accumulation in tomato cell suspension 
cultures.  Additionally, even higher uniform enrichments of tomato cell line-derived 13C-
carotenoids may be achieved by sequential growth cycles in 13C-glucose containing media.  
Future research will focus on the utilization of this highly enriched 13C-LYC as well as the 
production of 13C-PE and PF from norflurazon-treated hp-1 cell suspension cultures for 
mammalian cell culture and human studies.  The advances made in this work provide the 
opportunity for greater elucidation of mammalian carotenoid metabolism as well as underlying 
mechanisms of bioactivity.    
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Abbreviations Used:  
LYC, lycopene; PE, phytoene; PF, phytofluene; CPTA, 2-(4-chlorophenyl-thio)triethylamine; 
PTOX, plastid terminal oxidase; HPLC-PDA, high pressure liquid chromatography-photodiode 
array; BHT, butylated hydroxytoluene 
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Tables 
Table 3.1. Carotenoid Concentrations from gh and Wild-Type- Callus Cultures (One Trial, 
n = 5 Replicates)a.   
  Carotenoid concentrations (µg/g callus) ± SEM 
Ghost Cell 
Line Genotype 
Explant 
Tissue Type 
Phytoene Phytofluene Lycopene #%carotene 
wild-type Leaf n/d n/d 0.01 ± 0.00 0.06 ± 0.01 
 Flower bud n/d n/d 0.01 ± 0.00 0.06 ± 0.01 
gh Leaf 1.41 ± 0.24 trace 0.02 ± 0.01 0.04± 0.00 
 Flower bud 5.59 ± 1.82 0.16 ± 0.04 0.03 ± 0.00 0.03 ± 0.01 
a
Carotenoid concentrations represent the average of five samples ± the standard error of the mean (SEM).   
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Table 3.2. Carotenoid Concentrations from Control gh and Wild-Type Cell Suspension 
Cultures or Treated with CPTA for the 14 d growth cycle.a   
  Carotenoid concentrations (µg/g cells) 
GH Cell Line 
Phenotype 
Herbicide 
Treatment 
Phytoene Phytofluene Lycopene #%carotene 
wild-type CPTA 0.10 0.10 4.23 0.23 
 Control n/d trace 0.04 0.87 
gh CPTA 25.10 0.65 0.33 0.02 
 Control 30.87 0.75 0.19 0.17 
a
Carotenoid concentrations represent the average of two samples analyzed from one trial.   
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Table 3.3. Carotenoid Concentrations from Control gh and Wild-Type Cell Suspension 
Cultures Grown in Carotenoid Production Media for 14 Days and Treated with 
Norflurazon on Day 7.a   
  Carotenoid concentrations ( µg/g cells) 
GH Cell Line 
Genotype 
Herbicide 
Treatment 
Phytoene Phytofluene Lycopene #%carotene 
wild-type Norflurazon 9.53 0.65 0.05 0.41 
 Control 0.33 0.06 0.06 1.07 
gh Norflurazon 14.08 0.18 0.11 0.15 
 Control 15.03 0.33 0.05 0.17 
a
Carotenoid concentrations represent the average of two samples analyzed from one trial.  
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Table 3.4. Harvest Yields of Callus Cultures of High Lycopene Tomato Cell Lines and 
Available Wild-Type Cultures Grown on Agar-Solidified Carotenoid Production Medium 
with or without CPTA.a   
 Harvest Yield (g callus/3 g callus inoculum) ± SEM 
Tomato Cell Line  Control Treatment CPTA Treatment 
'VFNT cherry' 14.47 ± 1.79A 13.23 ± 1.28A 
'Manapal' wild-type 6.65 ± 0.35B 5.85 ± 0.25B 
'Manapal' hp-2 9.16 ± 1.42B 8.26 ± 1.68B 
'Ailsa Craig' wild-type 7.35 ± 0.71B 6.27 ± 0.35B 
'Ailsa Craig' hp-1 6.73 ± 0.23B 5.51 ± 0.21B 
L. pimpinellifolium 8.44 ± 1.84B 8.72 ± 0.77B 
'Suncoast' B^og 7.99 ± 0.35B 7.95 ± 0.31B 
a
Values represent the average mass yield of three trials with two reps per trial, where one rep was one container of 
agar-solidified medium inoculated with 3 g callus.  Statistically different yields within the treatment groups were 
detected by analysis of variance ($=0.05), and are denoted by different superscript letters. 
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Table 3.5.  Carotenoid Concentrations of Control-Treated and CPTA-Treated Tomato 
Callus Cultures Grown on Agar-Solidified Carotenoid Production Medium.a   
Carotenoid Concentration (µg/g cells) 
 
Phytoene Phytofluene Lycopene 
  
Control CPTA Control CPTA Control CPTA 
'VFNT' cherry 
0.48 ± 0.22 0.89 ± 0.09 0.35 ± 0.16 0.90 ± 0.07 1.16 ± 0.56 10.90 ± 3.72 
'Ailsa Craig'  
hp-1b 
0.44 ± 0.07 2.67 ± 1.02 0.32 ± 0.05 2.12 ± 0.50 0.62 ± 0.22 40.98±11.56 
'Ailsa Craig' WT 
0.32 ± 0.14 1.12 ± 0.15 0.23 ± 0.10 0.95 ± 0.12 0.41 ± 0.18 25.12 ± 4.28 
L. 
pimpinellifolium 
0.54 ± 0.10 0.96 ± 0.07 0.39 ± 0.07 0.70 ± 0.10 1.29 ± 0.52 15.40 ± 2.84 
Manapal' hp-2 
0.59 ± 0.15 1.59 ± 0.34 0.43 ± 0.11 1.73 ± 0.38 1.49 ± 0.61 28.01 ± 6.41 
'Manapal' WT 
0.45 ± 0.20 0.85 ± 0.08 0.32 ± 0.15 0.74 ± 0.07 0.95 ± 0.51 13.31 ± 1.10 
Suncoast' B^og 
0.54 ± 0.18 0.71 ± 0.01 0.39 ± 0.13 0.52 ± 0.00 0.91 ± 0.37 7.90 ± 1.56 
a
Average values of three trials with two replicate analyses per trial and SEM are presented.   
b
The CPTA-treated 'Ailsa Craig' hp-1 cell line had a significantly greater total carotenoid (phytoene + phytofluene + 
lycopene) concentration than all other treatments and cell lines as detected by analysis of variance ($ = 0.05). 
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Table 3.6. Carotenoid Concentrations and Harvest Yields from Tomato Cell Suspension 
Cultures Harvested 11 Months Postcell Suspension Culture Initiation.a   
  Carotenoid Concentration (µg/g cells) 
Harvest Yield  
(g cells/L culture) 
 Phytoene Phytofluene Lycopene   
  Control CPTA Control CPTA Control CPTA Control CPTA 
'VFNT' cherry 0.70 5.22 n/d 0.57 0.01 21.61 178 137 
'Ailsa Craig' hp-1 0.50 1.69 n/d 0.20 n/d 38.09 270 199 
'Ailsa Craig' WT 0.01 0.62 n/d 0.09 n/d 39.52 192 138 
'Manapal' hp-2 0.01 0.73 n/d 0.09 n/d 27.55 131 84 
'Manapal' WT 0.01 0.17 n/d 0.03 n/d 10.63 168 147 
a
Cultures were treated with or without CPTA and harvested after one 14 d growth period.  Each value represents the 
average of two samples.  Samples with either no signal for a carotenoid or a signal below accurate quantification are 
denoted at not detectable (n/d). 
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Figure 3.1. Simplified study design for derivation and selection of tomato cell lines for A. 
phytoene production from the ghost tomato cell line, and B. lycopene, phytoene, and phytofluene 
production from a high lycopene tomato cell line.
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Figure 3.1. (cont.) 
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Figure 3.2.  Lycopene concentrations (A) and yields (B) from different tomato cell lines 
suspension cultures treated with CPTA for a 14 day growth cycle and harvested approximately 
8.5, 10.5, or 11 months post-initiation of cell suspension cultures from callus cultures.  Each 
point represents the average of two samples.   
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Figure 3.3. Combined carotenoid (LYC, PF, 
and PE) yields from hp-1 tomato cell 
suspension cultures treated with different 
herbicides (n = 3 trials).  Error bars represent 
SEM of combined carotenoids.  Significantly 
different combined carotenoid yields ($ = 
0.05) detected by Tukey's studentized range 
test compared to control are noted with an asterisk (*). 
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Figure 3.4.  HPLC chromatograms (' = 472 nm) of (A) LYC analytical standard with all-E 
(peak 3) and 5-Z (peak 4) lycopene isomers eluting at 28 min with other preceding Z-isomers 
(RT = 22.5 and 24.5 min; peaks 1 & 2) and (B) purified 13C-all-E LYC from a hp-1 tomato cell 
suspension culture. 
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Figure 3.5. Mass isotopomers present in purified 13C-lycopene from hp-1 tomato cell culture 
treated with CPTA.  Percent isotopomer in sample is calculated from mass chromatogram peak 
signal areas obtained from four analytical injections of 13C-lycopene (1000 ng each in 40 !L 
diethyl ether); each injection yielded peak area signals for 6 masses selected, and sequential 
injections were normalized.  Signals for < m/z = 557 were not quantifiable.  In vitro labeling 
yields 45% uniformly labeled (m/z = 577) 13C-lycopene and a distribution of less enriched 
isotopomers (m/z= 557-576). 
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CHAPTER 4: 
Relative bioavailability of phytoene and lycopene and bioaccumulation of tomato 
carotenoids in tomato powder-fed Mongolian gerbils (Meriones unguiculatus) 
Abstract 
Tomato carotenoid consumption is associated with decreased risk of chronic disease 
development, including cardiovascular disease and prostate cancer.  Although lycopene (LYC) is 
often credited as the single bioactive, tomatoes provide a complex milieu of nutrients and 
bioactives including the carotenoids phytoene (PE), phytofluene (PF), "-carotene (ZC), and #-
carotene (BC).  The objective of this study was to determine the biodistribution of tomato 
carotenoids from a tomato containing diet as well as compare the relative bioavailability of PE 
and LYC in oil in a relevant animal model, the Mongolian gerbil. Tomato carotenoids 
accumulated in tissues and serum collected from gerbils fed 10% tomato powder diets for 26 
days and then fed a control diet for 2 days, with LYC being the primary carotenoid in serum, 
liver, spleen, lungs, testes, and prostate-seminal vesicle complex.  PF was the most concentrated 
carotenoid in the adrenal glands, while PE was the most concentrated carotenoid in the gonadal 
adipose.  LYC, PF, and ZC were detectable in all tissues evaluated, while BC was not detected in 
the testes, gonadal adipose, prostate-seminal vesicle complex, lung, or spleen, and PE was not 
detected in the prostate-seminal vesicle complex or the testes.  Kinetic dosing of tomato powder 
pre-fed gerbils with PE or LYC in oil showed that PE was more readily absorbed and 
biodistributed to the tissues, causing significant increases at 6, 12, and 24 hr after dosing in PE 
concentrations in serum (570%, 340%, and 650 %, respectively), liver (6 hr, 81%; 24 hr, 109%), 
and the spleen (1722%, 1400%, and 1633%, respectively) .  LYC dosing also significantly 
increased serum Z-LYC isomer concentrations at 6, 12, and 24 hours (90%, 60%, and 30%) and 
all-E LYC at 6 hours post-dosing (40%), but did not lead to significant increases in tissue LYC.  
This study suggests that the colorless carotenoid, PE, is more bioavailable than LYC in tomato 
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powder pre-fed gerbils, and that the gerbil is a suitable model for studying tomato carotenoid 
absorption and biodistribution. 
Introduction 
Epidemiological evidence suggests that tomato product consumption can decrease the risk of two 
widespread chronic diseases: cardiovascular disease and prostate cancer (1, 2).  Tomatoes 
contain a variety of nutrients and constituents that are part of a healthy diet such as folate, 
vitamin E, vitamin C, potassium, pro-vitamin A carotenoids, and fiber (3).  In addition to these 
nutrients, tomatoes are a rich source of carotenoids including lycopene (LYC), neurosporene, !-
carotene, #-carotene (BC), "-carotene (ZC), phytoene (PE), and phytofluene (PF).  Carotenoids 
are colorful tetraterpene molecules produced by plants, fungi, and bacteria, and were only 
recently discovered to be synthesized in animals (the pea aphid) (4), albeit exceptionally rare.  
Tomato carotenoids have a variety of bioactive functions that may relate to decreased chronic 
disease risk.  LYC has been most widely investigated as a potent antioxidant, inducer of phase II 
enzymes, supressor of cell proliferation, and upregulator of gap-junction communication (5).  
The colorless tomato carotenoids, PE and PF, similarly to LYC, are antioxidants and inhibit LDL 
oxidation in vitro (6).  Further, when mouse embryonic fibroblasts (NIH3T3) were engineered to 
produce PE, the cells were protected from oxidative stress as well as malignant transformation 
induced by oncogene transfection (7).  When rats were fed either PF, LYC, or tomato powder for 
4 d, their circulating androgens were depressed (8).  A small study of human autopsy tissue 
samples indicated that LYC, PE, PF, and ZC are accumulated at ng/g concentrations in liver, 
lung, and prostate tissues (9). Previous studies of tomato carotenoid bioaccumulation in rats 
suggested that PE, PF, LYC, and ZC are differentially accumulated in tissues and tissue 
carotenoid profiles did not directly mimic the profile of carotenoids provided in the diet.  
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Notably, PF was the predominant carotenoid in the liver, and PE and PF were the major 
carotenoids in the adrenal glands as well as serum (10).  LYC is known to be the predominant 
carotenoid accumulated in both the human prostate as well as the rat, a commonly used animal 
model of prostate cancer. However, PE, PF, and ZC also substantially accumulated in the rat 
prostate at 23, 36, and 23% of the level of LYC, respectively and at 12, 54, and 50% that of LYC 
in the human prostate (9-11).    
 The Mongolian gerbil has physiological similarities to humans for carotenoid, 
cholesterol, and lipid absorption and is thus an excellent model for carotenoid absorption and 
metabolism studies (12).  When gerbils were directly compared to F344 rats, BALB/c mice, and 
nude mice to evaluate LYC absorption and accumulation, it was found that gerbils most readily 
absorbed LYC, attaining plasma concentrations similar to those of humans with LYC dosing 
every other day (20 mg/kg BW!2d) accumulated the most hepatic LYC. This led to the 
conclusion that gerbils are the most suitable rodent species, of those evaluated, for studying the 
in vivo effects of LYC (13).    
 Previously, the gerbil was utilized to evaluate relative bioavailability of LYC from 
different sources: 60 µg/d of LYC was delivered for 21 days via purified oral doses of LYC, 
freeze-dried tomato paste or red carrot, or from red carrot or tomato paste extracts in oil (14).  
While LYC from a tomato product was evaluated, the uptake of PE, PF, and ZC was not.  
Furthermore, in the gerbil only serum, liver, adrenal, and testes have been studied. For a more 
complete picture of carotenoid biodistribution in this animal model, LYC, PE, PF, ZC, and BC 
accumulation in various tissues in response to tomato powder feeding should be evaluated (13, 
14).  Tissue carotenoid concentrations in an appropriate model will serve as a reference for future 
in vitro and in vivo study designs to examine the absorption, metabolism, and bioactivity of 
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tomato carotenoids. Currently, nothing is known about the relative uptake and biodistribution 
kinetics of a single oral PE or LYC dose in gerbil tissues.  A direct comparison of the absorption 
and biodistribution of PE and LYC will help to elucidate differences in absorption and 
biodistribution patterns of these two carotenoids.    
 In this current study, tomato carotenoid bioaccumulation was assessed in the serum, liver, 
spleen, adrenal glands, lungs, adipose, testes, and the prostate-seminal vesicle complex in gerbils 
fed 10% tomato powder diet for 26 days.  In addition, gerbils pre-fed tomato powder-containing 
diets were dosed with either cottonseed oil, PE in oil, or LYC in oil to compare the differential 
absorption and biodistribution of these carotenoids over a 24 hour time course.   
Materials and Methods 
Animals and Experimental Design 
This animal protocol was approved by the University of Illinois Institutional Animal Care and 
Use Committee and followed all necessary protocols to ensure humane treatment of the animals.  
Male, 40-day old Mongolian gerbils (38.12 ± 0.36 g BW) (Charles River Laboratories) (N = 56) 
were fed a pelleted chow diet (Teklad 8640, Harlan Laboratories, Madison, WI) for 2 days and 
were then fed a control, semi-purified, powdered diet published by Mills, et al. for 2 days (15) 
and were then randomized to either a control diet group (n = 7) or a 10% tomato powder diet 
group (n = 49) (Table 4.1, Figure 4.1).  The tomato powder diet provided all-E-LYC (213.6 
mg/kg), Z-LYC isomers (82.7 mg/kg), PE (11.7 mg/kg), PF (3.7 g/kg), ZC (5.5 g/kg), and BC 
(3.3 g/kg) (Futureceuticals, Momence, IL) (Figure 4.2), while the control diet provided 0.3 mg 
PE/kg diet andnone of the other carotenoids were detected. The tomato powder diet was 
balanced for macronutrients and fiber, with respect to the control diet (Table 4.1).  Over the next 
9 days, gerbils started their assigned study diets.  Throughout the study, animals were weighed 
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and fed fresh powdered diet (15 g) every 2 days.  Animals were assigned to dosing groups as 
follows: the tomato powder diet-fed animals were assigned to receive either an oral gavage of PE 
in cottonseed oil (TPPE group; n = 21), LYC in cottonseed oil (TPLY group; n = 21), or 
cottonseed oil alone (TPCO group; n = 7).  The control-diet fed animals were assigned to receive 
the cottonseed oil dose (CCO group) (n = 7) (Figure 1).  After 26 days on the study diet, all 
tomato powder fed animals were switched to a control diet for 2 days before carotenoid dosing to 
assure that there would not be any competition between dosed carotenoids and previously-fed 
dietary carotenoids for absorption.  On the basis of the dosing assignment, gerbils were placed 
under isoflurane anesthesia and were provided with either 1.31 ± 0.05 mg LYC in 206 ± 3 µL 
cottonseed oil, 1.00 ± 0.01 mg PE in 202 ± 3 µL cottonseed oil, or 206 ± 4 µL cottonseed oil 
only (TPCO group).  TPPE and TPLY animals were sacrificed at either 6, 12, or 24 hours after 
dosing (n = 7/timepoint) and TPCO animals were gavaged with cottonseed oil were sacrificed 6 
hours post-dosing (Figure 4.1).  At the time of sacrifice, gerbils were anesthetized with CO2 and 
blood was collected by cardiac puncture; then animals were euthanized by CO2 asphyxiation. 
The liver, adrenal gland, gonadal adipose, spleen, lung, testes, and the prostate-seminal vesicle 
complex tissues were collected, weighed, and snap frozen in liquid nitrogen, then stored at -80 
°C for further carotenoid analysis.   
Carotenoid analysis of diet composition 
Tomato powder and control diets were analyzed by first extracting 0.025 g diet using a 
previously-established protocol (16).  The HPLC analytical equipment and methods have been 
previously described (17). 
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Preparation of purified carotenoid doses 
General precautions for work with carotenoids were taken to prevent degradation and artifact 
formation during the extraction and analytical process (18).  PE doses were prepared from PE-
rich oil (Vitan Ltd., Dnepropetrovsk, Ukraine) by dissolving the PE-rich oil in chloroform and 
injecting onto a preparatory HPLC system that has been previously described (19).  LYC was 
extracted from Redivivo 10% LYC beadlets (DSM, Heerlen, Netherlands) using a modified 
protocol (BASF, personal communication) by adding 15 µL alcalase (Calbiochem, San Diego, 
CA) and a few crystals of BHT to 100 mg of beadlets, then 2.5 mL of 2% aqueous ammonium 
hydroxide solution was added.  The mixture was vortexed briefly and then heated in a shaking 80 
°C water bath for 2 min.  Five mL ethanol and 2 mL hexanes were added to the solution, it was 
vortexed, and the hexane layer was removed and reserved.  The hexanes extraction was repeated 
at least 5 times until the hexanes layer was no longer red.  The hexanes were combined and 
evaporated using an AS160 Savant Speedvac (Thermo Scientific, Pittsburgh, PA).  The 
concentrated LYC extract was then reconstituted in chloroform and injected onto the HPLC 
preparatory system described above.  LYC was collected and used for dose preparation.  Purified 
LYC and PE isomeric composition was evaluated and amounts were quantified using the 
analytical HPLC system described in Chapter 3.  Purified carotenoids were dispensed into 
separate vials to be opened fresh on each day of dosing; gerbil dosing was staggered over 9 days 
at the end of the study, to facilitate the pharmacokinetic aspect of the study.  Purified LYC doses 
consisted of 52 ± 2% in the all all-E isomer with the remainder in various Z isomers, while 100% 
of the phytoene was identified to be present in the 15-Z isomer.   Carotenoid doses were 
reconstituted in cottonseed oil daily, using chloroform to solubilize the carotenoid, adding 
cottonseed oil, and evaporating the chloroform under a stream of argon gas (10).  Complete 
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evaporation of chloroform was confirmed gravimetrically.  Doses were administered to gerbils 
by oral intubation and the dose mass administered was recorded.  Carotenoid dose samples from 
each day were reserved for confirmatory HPLC analysis.   
Serum and tissue HPLC analyses 
Serum and tissue extraction methods were previously described (10).   
Statistical analyses 
Tissue carotenoid concentrations from TPPE and TPLY animals at 6, 12, and 24 hours 
postdosing were compared to each other and to the TPCO group.  Significant differences were 
determined by using the post-hoc Tukey's studentized range test ($ = 0.05) within ANOVA 
when the assumptions of ANOVA were met, otherwise the Wilcoxon and Kruskal-Wallis non-
parametric tests were used to evaluate group differences ($ = 0.05) using the statistical analysis 
software SAS v. 7.1 (SAS Institute Inc., Cary, NC).  All results are presented at an average of the 
analyses ± the standard error of the mean (SEM), unless otherwise noted. 
Results 
Animal weight gain 
 Gerbil final weight did not differ by diet, dosing group, or sacrifice time point (p = 0.06).  
Average gerbil weight at time of sacrifice was 67.8 ± 0.5 g. 
Tomato carotenoid biodistribution in tomato powder-fed, cottonseed oil-dosed gerbils 
 Gerbils from the TPCO group were sacrificed six hours after dosing to evaluate tomato 
carotenoid bioaccumulation.  Prior to dosing, gerbils were fed the control diet for two days to 
minimize variability of serum and tissue carotenoid concentrations as a result of tomato-powder 
feeding.  The relative proportions of measured tomato carotenoid in the tomato-powder diet were 
67% all-E LYC, 26% Z-LYC isomers, 3% PE, 2% ZC, 1% PF, and 1% BC (Figure 4.2), 
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however the relative proportions accumulated in tissues differed substantially from that in the 
tomato powder.   The primary carotenoids present in the serum were PE, PF and LYC, with the 
majority of LYC present as Z isomers (58%), and there were lesser amounts of ZC, and BC 
(Table 4.2, Figure 4.3).  Of all tissues analyzed, carotenoids were most concentrated in the liver 
tissue (Figure 4.4) where LYC was the predominant accumulated carotenoid (74% Z isomers, 
26% all-E) followed by PF, then lesser amounts of PE, ZC, and BC (Table 4.3, Figure 4.5).  The 
most prominent carotenoid in the adrenals was PF, followed by PE, then LYC (83% Z and 17% 
all-E), ZC, and BC (Table 4.4, Figure 4.5).  Spleen tissue primarily accumulated LYC (59% Z 
and 41% all-E), followed by PF, with lower amounts of PE and ZC, and BC was not detected 
(Table 4.5, Figure 4.5).  Both PF and LYC (67% Z and 33% all-E) were the most prominent 
carotenoids in the lung tissue followed by ZC then PE, and BC was not detectable (Table 4.6, 
Figure 4.5).  PE was the greatest accumulated carotenoid in the gonadal adipose followed by 
LYC (57% Z and 43% all-E), then ZC and PF (Table 4.7, Figure 4.5).  Two androgen-sensitive 
tissues were analyzed and of those two, carotenoid concentrations were about 3.5-times greater 
in the testes than in the prostate-seminal vesicle complex.  In the testes, LYC was most 
prominent (74% Z isomers and 26% all-E) followed by PF and ZC, while BC and PE were not 
detected (Table 4.8, Figure 4.6).  Similarly, the prostate and seminal vesicle complex 
accumulated more LYC (58% Z isomers, and 42% all-E isomers) than PF and ZC, and BC and 
PE were not detectable (Table 4.9, Figure 4.6). Tissues and serum of CCO animals were 
analyzed and carotenoids were not detected in the adrenals, prostate-seminal vesicle complex, 
serum, or testes, while PE was detected in the liver (1.27 ± 0.37 µg/g) and traces of other 
carotenoids (3.5 µg total carotenoids/g) were also present, likely due to transient tomato powder 
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exposure during weighing and cage changes.  CCO group also had trace LYC detected in the 
spleen (0.07 µg/g), and LYC and ZC in the lung tissue (21.43 ng/g and 2.95 ng/g, respectively). 
Effect of PE or LYC-dosing on serum and tissue carotenoid concentrations 
 Serum and tissue carotenoid concentrations were examined at 6, 12, and 24 hours 
postdosing in TPPE and TPLY groups, and these carotenoid concentrations were compared to 
the TPCO group sacrificed 6 hours after dosing.  Serum PE increased in response to PE dosing 
and that increase was sustained over the 24 hour period monitored (Table 4.2, Figure 4.7).  
Serum Z-LYC isomers increased in response to LYC dosing and remained greater than the 
TPCO group for the 24 hour duration while the all-E LYC serum concentration was only 
elevated through 12 hour post-LYC dosing and returned to the TPCO levels at 24 hour.  Serum 
ZC, PF, and ZC were not impacted by carotenoid dosing.   
 Liver PE concentrations increased in response to PE dosing over the 24 hour time-course, 
however, neither Z nor all-E LYC concentrations were impacted by LYC dosing (Table 4.3, 
Figure 4.7).  Liver PF, ZC, and BC concentrations were not affected by carotenoid dosing.  
Alternatively, adrenal PE was not different in TPPE animals compared to TPCO group, but 
TPLY animals had greater Z-LYC isomer concentrations 12 hours after dosing compared to 
TPCO animals while all-E LYC concentrations did not differ over 24 hours (Table 4.4, Figure 
4.7).  At 12 hours post-dosing, PE-dosed gerbils had greater PF and ZC adrenal gland 
concentrations than LYC dosed animals and greater BC than the TPCO animals (Table 4.4).  PE 
dosing led to an increase in spleen PE concentrations over the 24 hr period, but LYC dosing did 
not increase LYC concentrations in the spleen (Table 4.5).  Lung PE concentrations increased 6-
fold at 24 hours post-PE dosing, but pulmonary LYC did not increase in response to LYC-
dosing.  BC, ZC, and PF concentrations in the lung tissue were not affected by carotenoid dosing 
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(Table 4.6).  Carotenoid dosing did not have a significant impact on gonadal adipose carotenoid 
concentrations over time (Table 4.7).  The testes and prostate-seminal vesicle complex did not 
have detectable PE over the 24 hour time-course (Tables 8 & 9).  PE-dosed animals had lower 
testes Z-LYC concentrations 6 and 12 hours post-dosing as well as decreased PF at 6 hours and 
ZC at 12 hours post-dosing.  At 12 hours post PE-dosing, there was greater all-E LYC and ZC 
compared to the TPCO animals. 
Discussion 
 TPCO animals accumulated tomato carotenoids in all of the evaluated tissues as well as 
in serum.  In this study, the gerbils were fed a control diet for two days prior to dosing to allow 
carotenoids to be cleared from the gastrointestinal tract so that carotenoid interactions were not a 
factor during the oral dosing study.  Although the gerbils had not consumed carotenoids for at 
least two days before serum was collected, PE, PF, LYC, ZC, and BC were all detected, however 
they were present at 10-fold or lower concentrations (0.026, 0.022, 0.040, 0.011, and 0.008 
ng/µL, respectively) than those previously reported for humans that consumed a high LYC 
tomato juice for 4 wk (PE, 0.16; PF, 0.39; LYC, 0.40; ZC, 0.14; BC 0.22 ng/µL plasma) (20).  
Gerbil hepatic carotenoid concentrations (LYC, 72; PF, 36; PE, 13; ZC, 6 µg/g) (Table 4.3) were 
much higher than those reported in humans (LYC, 352; PF, 261; PE, 168; ZC, 150 ng/g), though 
the human tissue examined was taken from autopsy specimens and not from a feeding study (9).  
It may be reasonable to expect that with regular tomato consumption, human liver carotenoid 
concentrations would be greater than autopsy samples.  However, the accumulated hepatic 
carotenoid profile in gerbils is similar to humans, such that LYC > PF > PE, but with the 
exception that gerbils accumulated more ZC than BC in contrast to what is observed in humans 
(9). The adrenal glands had the next greatest carotenoid concentrations after the liver (Table 4.4).  
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The adrenal glands are a site of steroid synthesis, and thus necessitate high cholesterol uptake via 
the SR-B1 transporter, which is also known to transport carotenoids (21).  Human adrenal 
glandular carotenoid concentrations have not been previously reported to our knowledge but the 
findings for gerbils are similar to what is seen in the rat such that PE and PF are nearly 
equivalent while there are lesser amounts of accumulated LYC and ZC (10).  Gerbil splenic 
carotenoid accumulation (Table 4.5) was similar in the accumulation profile to rats such that 
LYC was most prominent followed by PF and lesser amounts of ZC and PE, but gerbils 
accumulated less total carotenoids than the rat (10).  Pulmonary carotenoid accumulation in the 
gerbil (Table 4.6) differed from what has been reported for the human autopsy samples (9).  
Gerbil pulmonary carotenoid concentrations of LYC and PF were greatest, followed by ZC and 
PE, while BC was below detection. In humans PE is the major pulmonary tomato carotenoid 
observed followed by LYC, BC, PF, and ZC (9).  Adipose tissue is viewed as a major depository 
for carotenoids because of the large size of this tissue although there are typically low 
concentrations of carotenoids (21).  Carotenoid concentrations measured in the gonadal adipose 
tissue site showed that although gerbils accumulated ng/g amounts of tomato carotenoids, the 
carotenoid profile differed substantially from that observed in rats (gerbils, PE > LYC > ZC > 
PF; vs. rats, LYC > PF > PE > ZC)(10).  
 Androgen-sensitive tissues have been previously reported to differ in carotenoid 
accumulation profiles from other tissues, such that LYC is preferentially accumulated (9, 10). In 
this current study, the intact prostate-seminal vesicle complex and the testes from gerbils were 
analyzed for carotenoid content.  In human autopsied prostate samples, LYC was most 
prominent (374 ng/g) followed by PF, ZC, BC, and PE (201, 187, 163, and 45 ng/g, respectively) 
(9).  Similar to humans, LYC is the most prominent carotenoid in the gerbil prostate-seminal 
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vesicle complex, followed by ZC then PF; BC and PE were not detected.    Rats had a different 
distribution of carotenoids in the seminal vesicles with the major carotenoid being LYC (53.7 
ng/g) followed by equal amounts of PE and PF and a lesser amount of ZC (10).  Similarly to 
gerbil prostatic-seminal vesicular carotenoid profile, LYC is the major carotenoid present in 
gerbil testes followed by PF then ZC.  In the rat, LYC and PF are the major testicular carotenoids 
followed by PE and ZC (10).  It appears that in both rats and gerbils, LYC and PF are 
prominently accumulated in the testes, and LYC is predominant in the prostate.  Data on human 
testicular PE and PF concentrations are not currently available. It is interesting to note the 
contrast between the steroidogenic tissues examined in that the adrenal gland preferentially 
accumulates PF and PE, while the androgenic testes accumulate primarily LYC.   
 Serum and adipose tissue carotenoid concentrations are popular epidemiologic and 
clinical markers for carotenoid exposure, however our findings along with those for the rat 
indicate that while serum and adipose are useful to provide indication of which carotenoids have 
been consumed, these measures are not representative of the amounts of carotenoids that are 
accumulated in other tissues.  Often, in vitro studies base carotenoid dosing levels on serum 
concentrations when it may, in fact, be more relevant to base dosing levels on tissue 
concentrations determined in an appropriate animal model.   
 Oral carotenoid dosing in oil led to concomitant increases of the dosed carotenoid in the 
serum.  PE dosing increased serum PE by 570% at 6 hours, 340% at 12 hours, and 650% at 24 
hours, while LYC dosing increased Z LYC isomers in serum 90% at 6 hours, 60% at 12 hours, 
and 30% at 24 hours, while all-E LYC was only increased at the 6 hour time-point by 40% and 
was not significantly different from TPCO animals at the subsequent time-points.  In short, the 
PE dose was absorbed to a greater extent than the LYC dose although the PE dose mass was less 
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than that of the LYC dose.  This difference may be due to PE being present primarily in a Z-
isomeric conformation.  Previous studies with LYC have shown Z-isomers to be less prone to 
aggregation and crystallization and therefore more likely to be incorporated into bile acid 
micelles (21).  While PE-dosing increased serum PE and LYC-dosing increased serum LYC, 
each for the 24 hour duration, not all tissues showed the same increase in carotenoids in response 
to dosing.  Hepatic and splenic PE increased after PE-dosing in agreement with what was 
observed in rats provided with a PE-dose (10), however LYC did not increase in response to 
LYC-dosing in either tissue.  The adrenal glands, alternatively, showed an increase in Z-LYC 
isomer accumulation at 12 hours post-PE-dosing, but there was not a rise in adrenal PE during 
the 24 hour time-course, in agreement with previous findings in rats dosed with PE (10).  
Pulmonary PE concentrations were elevated 24 hours post-PE-dosing suggesting that this tissue 
may be subject to a lag in carotenoid uptake after dosing.  Carotenoid dosing did not impact 
gonadal adipose tissue carotenoid concentrations though there was a trend for an increase in 
adipose PE at the 24 hour timepoint.  Taken together, the results suggest that although both LYC 
and PE were absorbed from the doses, PE was more readily absorbed and accumulated in the 
liver and spleen, while LYC was accumulated more readily in the adrenal gland tissue.  The lung 
and gonadal adipose tissues were not as responsive to the carotenoid doses, though by 24 hours 
there was a modest increase in tissue PE in each tissue.  These differences in tissue responses to 
carotenoids may be due to differences in carotenoid packaging into chylomicrons as well as 
lipoproteins, or absorption into cells.  Since the increase in serum LYC was less than that of PE, 
it suggests that PE may be more easily taken up into intestinal cells or more easily absorbed into 
the lymphatic blood system than LYC.  
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 PE and LYC concentrations in the androgen-sensitive tissues did not increase 
significantly in response to the single oral dose.  However, when dosed with PE, gerbils had 
lower testicular Z-LYC concentrations compared to the TPCO group, suggesting that the LYC 
dose may have contributed to maintaining the testicular LYC levels over time.   Testicular LYC 
may have decreased over the 24 hour time span in TPPE animals due to LYC metabolism. 
Similarly to the testes, prostatic and seminal vesicular PE and LYC were not impacted by 
corresponding doses.  Interestingly, PE was not clearly detected in either of these androgen 
sensitive tissues, which suggests these tissues may differ in absorption or metabolism of PE, 
compared to the other tissues examined.  The testicular LYC concentrations reported here are 
much greater that those previously reported for gerbils consuming LYC daily, but the previous 
study provided a lower levels of LYC (60 µg/d) in the forms of cottonseed oil doses of tomato 
paste extract, red carrot extract, or purified all-E LYC (14), whereas, the gerbils in the present 
study consumed an estimated 7.5 g of 10% tomato powder diet/d, and thus were receiving 
approximately 2.23 mg LYC/d.   
 One of the most striking outcomes of this study is the differential absorption and 
bioavailability of the different carotenoids from tomato powder.  LYC is present in the tomato 
powder diet at levels 54 times that of ZC, 26 times the level of PE, and 80 times that of PF but 
does not accumulate in the tissues at such disparate levels, rather LYC is accumulated at similar 
levels in tissues to these more minor dietary carotenoids.  This disconnect between dietary LYC 
levels and tissue levels may be due to low bioavailability of LYC because of the prominent all-E 
conformation in tomato powder, which is less bioavailable than Z isomers; whereas the other 
carotenoids are found in primarily Z isomers (22).  The difference may also be due to elevated 
LYC metabolism.  Some evidence from our laboratory suggests that LYC is a substrate for the 
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CMO II enzyme, while PE and PF are not (23).  This was shown when CMOII knockout mice 
were fed LYC-containing diets and LYC significantly increased in tissues compared to WT and 
CMOI knockout mice.  It should also be noted that the gerbils in this study do not have sterile 
gastrointestinal tracts, therefore it is possible that gut microbiota played a role in tomato 
carotenoid bioavailability or metabolism.  Gut flora may be important for release of carotenoids 
from a fibrous matrix (24, 25), but there is little support in the literature for microbial 
metabolism of carotenoids in the gastrointestinal tract (26).   Further research using labeled 
carotenoid tracers should confirm if there is differential metabolism of PE, PF, and LYC in 
gerbil tissues. 
 In conclusion, we have shown that gerbils fed a 10% tomato powder diet for 26 days 
accumulated biologically relevant tissue concentrations of tomato carotenoids when compared 
with concentrations reported in humans.  Additionally, we have shown that the dietary 
carotenoid profile did not directly relate to gerbil tissue carotenoid profiles.  A possible 
explanation for differences in bioaccumulation of these linear carotenoids may be due to 
differential bioavailability of carotenoids as demonstrated by the PE and LYC dosing 
experiment, which showed PE is more bioavailable than LYC when delivered in an oil dose.  
Alternatively, LYC may be a substrate for the CMO II enzyme, which may explain lower LYC 
concentrations observed in gerbils fed high amounts of LYC.  Further studies utilizing 
radiolabeled PE and LYC will answer several remaining questions.  Radioactively labeled 
carotenoids offer the advantage of being able to be identified at low tissue concentrations and in 
altered metabolic product forms. For example, by providing 14C-PE, it will be determined if PE is 
being taken up into the testes and being metabolized or not.  Additionally, labeled LYC dosing 
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will indicate if LYC is more readily metabolized in the gerbil than PE providing an explanation 
for lower concentrations of LYC than PE in the gerbil in response to dosing. 
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Figures 
Figure 4.1. General study design for gerbil feeding and carotenoid dosing study.  Gerbils (n = 
56) were adapted to their new environment and to powdered diet over 2 days.  For the 
subsequent 26 days they were fed either control diet (n = 7) or 10% tomato powder diet (n = 49).  
After 26 days, all gerbils were fed a control diet for 2 days.  On day 30, the gerbils were dosed 
(gastric intubation) with either cottonseed oil, PE in cottonseed oil, or LYC in cottonseed oil.  
Animals were sacrificed 6, 12, or 24 hours postdosing. 
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Figure 4.2. Carotenoid concentrations in the 10% tomato powder diet.  Bars respresent the 
average of three replicates and errors bars represent the standard error of the mean. 
 
 
 
 
 
 
 
 
 
Figure 4.3. Serum carotenoid concentrations in gerbils fed a 10% tomato powder diet for 26 
days followed by 2 days of control diet-feeding. 
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Figure 4.4. Total carotenoid concentrations in various gerbil tissues in response to feeding a 
10% tomato powder diet for 26 days followed by 2 days of control diet-feeding. 
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Figure 4.5. Carotenoid accumulation in (A) liver, (B) adrenal glands, (C) spleen, (D) lung, and 
(E) gonadal adipose in response to tomato powder feeding for 26 days followed by 2 days of 
control diet consumption.  Bars represent the average of seven sample analyses and error bars 
represent the standard error of the mean. 
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Figure 4.6. Carotenoid accumulation in the (A) prostate-seminal vesicle complex and (B) testes 
in response to tomato powder feeding for 26 days followed by 2 days of control diet 
consumption.  Bars represent the average of seven sample analyses and error bars represent the 
standard error of the mean. 
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Figure 4.7. Carotenoid concentrations time-course over 24 hours in gerbil serum (A-C), liver 
(D), and spleen (E) after being pre-fed either a control diet and dosed with cottonseed oil (CCO), 
or pre-fed with 10% tomato powder diet and dosed with cottonseed oil (TPCO), phytoene in oil 
(TPPE), or lycopene in oil (TPLY). Each data point represents the average of 7 sample analyses 
and error bars represent standard error of the mean. 
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Tables 
Table 4.1. Gerbil diet composition. 
 
Control 
Diet 
10% 
Tomato 
Powder 
Diet 
Component g/kg  g/kg 
Sucrose 361 319.78 
Casein 1 200 186.1 
Cornstarch 150 150 
Maltodextrin 120 108.96 
Cottonseed Oil 60 55.14 
Cellulose 60 43.81 
Mineral Mix 2 35 35 
Vitamin Mix 3 5 5 
L-cystine 3 3 
Choline 
bitartrate 2.5 2.5 
CaHPO4 2 2 
MgO 1.75 1.75 
Tomato Powder 4 0 100 
   
kcal/g 3.78 3.78 
1
Vitamin-free test casein, contains 0.9 g protein/g casein. 
2
AIN-93G-MX (Teklad) provides calcium carbonate (12.495 g/kg diet); potassium phosphate, monobasic (6.86 g/kg 
diet); potassium citrate, monohydrate (2.48 g/kg diet); sodium chloride (2.59 g/kg diet); potassium sulfate (1.63 g/kg 
diet); magnesium oxide (0.85 g/kg diet); ferric citrate (0.21 g/kg diet); zinc carbonate (0.06 g/kg diet); manganous 
carbonate (0.02 g/kg diet); cupric carbonate (0.01 g/kg diet); potassium iodate (3.5 *10^-4 g/kg diet); sodium 
selenate (3.605*10^-4 g/kg diet); ammonium paramolybdate, tetrahydrate (2.8*10^-4 g/kg diet); sodium meta-
silicate, nonahydrate (0.0575 g/kg diet); chromium potassium sulfate, doceahydrate (9.6*10^-3 g/kg diet); lithium 
chloride (6.09 * 10^-4 g/kg diet); boric acid (2.85*10^-3 g/kg diet); sodium fluoride (2.22*10^-3 g/kg diet); nickel 
carbonate hydroxide, tetrahydrate (1.11 *10^-4 g/kg diet); ammonium meta-vanadate (2.31*10^-4 g/kg diet);  and 
sucrose (7.73 g/kg diet) (27). 
3
AIN-93-VX (Teklad) provides niacin (0.015 g/kg diet); calcium pantothenate (0.008 g/kg diet); pyridoxine HCl 
(3.5 *10^-3 g/kg diet); thiamin HCl (3*10^-3 g/kg diet); riboflavin (3*10^-3 g/kg diet); folic acid (1*10^-3 g/kg 
diet); biotin (1*10^-4 g/kg diet); vitamin B12 (0.1% in mannitol) (0.0125 g/kg diet); vitamin E, DL-alpha tocopheryl  
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Table 4.1. continued. 
acetate (500 IU/g)  (0.075 g/kg diet); vitamin A palmitate (500,000 IU/g) (0.004 g/kg diet); vitamin D3 
cholecalciferol (500,000 IU/g) (0.001 g/kg diet); vitamin K1, phylloquinone (3.75 *10^-4 g/kg diet); sucrose (4.87 
g/kg diet) (27). 
4
Drum dried tomato powder (Futureceuticals, Momence, IL) contains approximately 3.68 kcal/g, 0.01 g protein/g, 
0.03 g fat/g, 0.16 g fiber/g, and 0.52 g carbohydrate/g. 
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Table 4.2. Gerbil serum carotenoid concentrations 1, 2. 
Hours Post-
dosing:   6 12 24 
mean ± SEM 
(ng/dL ) Cottonseed Oil  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  
Phytoene $   2.6 ± 1.2 2.8 ± 0.8 A  17.4 ± 2.8 *, B  2.5 ± 1.1 A  11.4 ±3.4 *, B  2.2 ± 1.0 A  19.4 ± 4.7 *, B  
Z-Lycopene 
isomers $  2.3 ± 0.3 4.3 ± 0.7 *, B  1.7 ± 0.1A  3.7 ± 0.2 *, B  1.8 ± 0.1A  3.0 ± 0.3* 1.9 ± 0.1 
all-E Lycopene 1.7 ± 0.2 2.3 ± 0.2 *, B  1.6 ±0.1 2.3 ± 0.1B  1.7 ± 0.2A  2.1 ± 0.3  1.7 ± 0.1 
Phytofluene 2.2 ± 0.3 2.6 ± 0.6 2.2 ± 0.3 2.2 ± 0.2 1.8 ± 0.2 3.3 ± 0.6 2.5 ± 0.3 
Zeta-carotene 1.1 ± 0.1 1.3 ± 0.2 1.1 ± 0.1 1.1 ± 0.0 1.1 ± 0.0 1.4 ± 0.2 1.3 ± 0.1 
Beta-carotene 0.8 ± 0.1 0.9 ± 0.1 0.8 ± 0.0 0.9 ± 0.0 0.9 ± 0.1 0.9 ± 0.2 0.9 ± 0.1 
1
n = 6-7/dosing group; carotenoids were provided in 1 mg doses.2Significant differences between PE and LYC animals at different time points versus cotton-seed 
oil dosed animals at 6 hr post-dosing are denoted by an asterisk (*).  Significant differences between PE and LYC dosed groups at a specific time point are 
denoted by a capital letter.   Significant differences were detected using Tukey’s Studentized Range test within ANOVA. 
($ except for differences in phytoene and cis-lycopene concentrations where the Kruskal-Wallis non-parametric t-test due to a violation of homogeneity of 
variance)  
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Table 4.3. Gerbil liver carotenoid concentrations 1, 2 
Hours Post-dosing:   6  12 24 
mean ± SEM (µg/g) 
Cottonseed 
Oil  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  
Phytoene   13.31 ± 3.38 11.77 ± 2.59A  24.14 ± 2.29*,B  16.80 ± 2.18  22.03 ± 2.14 13.87 ± 0.97A, $  27.98 ± 1.12*,B, $  
Z-Lycopene isomers 
56.11 ± 
12.75 49.69 ± 9.72 63.65 ± 6.18 66.55 ± 7.61 50.76 ± 0.86 56.46 ± 5.20 45.74 ± 6.63 
all-E Lycopene 15.76 ± 2.98  13.28 ± 1.96 17.67 ± 0.96 19.53 ± 2.98  16.65 ± 2.42 15.12 ± 1.21  14.74 ± 1.70 
Phytofluene 36.28 ± 7.11 28.36 ± 4.39 42.06 ± 3.15 38.67± 4.60 32.15 ± 2.92 38.85 ± 2.51 32.11 ± 2.30 
Zeta-carotene 6.26 ± 1.20 4.81 ± 0.82  6.68 ± 0.84 6.25 ± 0.71 5.35 ± 0.38  6.55 ± 0.40  5.99 ± 1.04 
Beta-carotene 2.58 ± 0.46  2.37 ± 0.40 2.67 ± 0.29 2.38 ± 0.26 2.04 ± 0.08 2.76 ± 0.14  2.20 ± 0.12 
 
1 n = 6-7/dosing group  
2 Significant differences between PE and LYC animals at different time points versus cottonseed oil dosed animals at 6 hr post-dosing are denoted by an asterisk 
(*).  Significant differences between PE and LYC dosed groups at a specific time point are denoted by a capital letter.   Significant differences were detected 
using Tukey’s Studentized Range test within ANOVA. 
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Table 4.4. Gerbil adrenal carotenoid concentrations1, 2 
Hours Post-dosing:   6  12  24 
mean ± SEM (µg/g ) 
Cottonseed 
Oil  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  
Phytoene   8.54 ± 1.16 7.17 ± 0.73  9.41 ± 0.92 6.58 ± 0.64 12.78 ± 0.92 9.12 ± 1.02 11.49 ± 1.18 
Z-Lycopene isomers  3.41 ± 0.67 3.40 ± 0.60  3.86 ± 1.12  2.35 ± 0.46A  3.95 ± 0.54*,B  3.07 ± 0.56 2.65 ± 0.53  
all-E Lycopene 0.71 ± 0.08 0.62 ± 0.07  0.68 ± 0.14  0.62 ± 0.06 0.69 ± 0.05 0.71 ± 0.13  0.67 ± 0.10 
Phytofluene 10.38 ± 1.08  10.13 ± 1.06 10.34 ± 1.00 8.14 ± 0.59A  12.02 ± 0.87B  10.95 ± 1.12  7.13 ± 1.33 
Zeta-carotene 1.57 ± 0.19 1.60 ± 0.22 1.67 ± 0.18 1.23 ± 0.12A  1.80 ± 0.13B  1.75 ± 0.22 2.60 ± 0.13 
Beta-carotene 0.34 ± 0.02 0.33 ± 0.03  0.40 ± 0.05 0.40 ± 0.02  0.44 ± 0.03* 0.40 ± 0.04 0.36 ± 0.04 
 
1 n = 6-7/dosing group 
2 Significant differences between PE and LYC-dosed animal tissue concentrations at different time points versus cottonseed oil dosed animals at 6 hr post-dosing 
are denoted by an asterisk (*).  Significant differences between PE and LYC dosed groups at a specific time point are denoted by a capital letter.   Significant 
differences were detected using Tukey’s Studentized Range test within ANOVA. 
 118 
Table 4.5. Gerbil spleen carotenoid concentrations1, 2 
Hours Post-dosing:   6 12 24 
mean  ± SEM(µg/g) Cottonseed Oil  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  
Lycopene 
Dose  Phytoene Dose  
Phytoene   0.09 ± 0.03 0.17 ± 0.03A  1.64 ± 0.23*B  0.12 ± 0.03A  1.35 ± 0.19*B  0.17 ± 0.06A  1.56 ± 0.30*B  
Z-Lycopene isomers 0.83 ± 0.09 1.19 ± 0.21 1.02 ± 0.29 1.28 ± 0.13 0.98 ± 0.15 1.21 ± 0.19 1.42 ± 0.25 
all-E Lycopene 0.58 ± 0.07 0.80 ± 0.17 0.71 ± 0.17 0.97 ± 0.22 0.71 ± 0.06 0.75 ± 0.11  0.92 ± 0.10 
Phytofluene 0.93 ± 0.13 1.28 ± 0.20 1.12 ± 0.22 1.23 ± 0.10  1.14 ± 0.16  1.32 ± 0.05 1.59 ± 0.17* 
Zeta-carotene 0.12 ± 0.02 0.17 ± 0.03 0.13 ± 0.03 0.14 ± 0.01  0.14 ± 0.02 0.20 ± 0.01 0.23 ± 0.03 
Beta-carotene n/d  n/d  n/d  n/d  n/d  n/d  n/d  
 
1 n = 6-7/dosing group  
2 Significant differences between PE and LYC-dosed animal tissue concentrations at different time points versus cottonseed oil dosed animals at 6 hr post-dosing 
are denoted by an asterisk (*).    Significant differences between PE and LYC dosed groups at a specific time point are denoted by a capital letter.   Significant 
differences were detected using Tukey’s Studentized Range test within ANOVA. 
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Table 4.6. Gerbil Lung Carotenoid Concentrations 1. 2 
Hours Post-dosing:   6 12 24  
mean ± SEM (ng/g) Cottonseed Oil  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  
Phytoene $  12.97 ± 5.86 36.21 ± 26.58  15.86 ± 4.58  9.32 ± 5.40 25.63 ± 16.78  20.32 ± 5.10A  91.04 ± 36.07B,* 
Z-Lycopene isomers 56.26 ± 11.18  52.52 ± 5.56 48.11 ± 4.54 60.67 ± 7.69 38.72 ± 3.58 59.77 ± 13.44 62.64 ± 17.65  
all-E Lycopene  28.11 ± 5.89  31.98 ± 1.44 28.02 ± 1.84 32.90 ± 1.89 25.40 ± 2.50 35.10 ± 4.82  35.29 ± 5.70 
Phytofluene   82.96 ± 11.28 73.24 ± 9.92 63.54 ± 7.01 60.99 ± 6.52  48.67 ± 4.14  80.88 ± 6.00  83.79 ± 18.21 
Zeta-carotene 36.03 ± 3.22 38.97 ± 2.05 35.66 ± 2.26 32.90 ± 0.88 29.75 ± 2.16 38.97 ± 1.92 39.49 ± 4.37 
Beta-carotene n/d  n/d  n/d  n/d  n/d  n/d  n/d  
 
1 n = 6-7/dosing group 
2 Significant differences between PE and LYC-dosed animal tissue concentrations at different time points versus cottonseed oil dosed animals at 6 hr post-dosing 
are denoted by an asterisk (*).    Significant differences between PE and LYC dosed groups at a specific time point are denoted by a capital letter.   Significant 
differences were detected using Tukey’s Studentized Range test within ANOVA. 
$ except for differences in phytoene concentrations where the Kruskal-Wallis non-parametric t-test due to a violation of homogeneity of variance 
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Table 4.7. Gerbil Gonadal Adipose Carotenoid Concentrations1, 2 
Hours Post-dosing:   6 12 24 
mean ± SEM(ng/g ) Cottonseed Oil  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  
Phytoene   44.12 ± 21.39 58.19 ± 21.01 55.77 ± 21.09 64.06 ± 21.86 46.86 ± 18.62 40.59 ± 9.87  86.78 ± 30.24 
Z-Lycopene   20.75 ± 7.45 19.44 ± 9.78 10.12 ± 6.57 22.16 ± 5.80 18.01 ± 8.72 14.01 ± 8.87 25.33 ± 8.31 
all-E Lycopene 15.69 ± 5.62 12.05 ± 5.76 7.21 ± 4.68 14.13 ± 5.03 11.80 ± 5.58 8.56 ± 5.41  18.30 ± 5.92 
Phytofluene   16.69 ± 6.48 15.10 ± 5.38 18.40 ± 4.40 9.49 ± 5.23  11.10 ± 5.71  17.92 ± 11.38 18.35 ± 6.52 
Zeta-carotene 21.98 ± 5.94 31.23 ± 2.74 29.16 ± 1.69 26.07 ± 2.48 17.95 ± 6.48 25.28 ± 6.04 26.34 ± 5.61 
Beta-carotene n/d  n/d  n/d  n/d  n/d  n/d  n/d  
 
1 n = 6-7/dosing group; carotenoids were provided in ~1 mg doses.  
2 Significant differences were not detected. 
n/d = not detected 
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Table 4.8. Gerbil Testes Carotenoid Concentrations1, 2 
Hours Post-dosing:   6 12 24 
mean ± SEM(ng/g ) Cottonseed Oil  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  
Phytoene   n/d  n/d  n/d  n/d  n/d  n/d  n/d  
Z-Lycopene   159.86 ± 31.52  84.86 ± 20.47  65.16 ± 21.98*  116.80 ± 26.14  56.81 ± 17.68*  84.22 ± 22.37  76.89 ± 20.70  
all-E Lycopene 56.52 ± 11.73  33.76 ± 6.35  29.93 ± 8.24  42.59 ± 9.02  27.83 ± 6.39  33.21 ± 7.46  36.87 ± 6.87  
Phytofluene 93.28 ± 18.63  64.38± 10.09  43.20 ± 7.61*  64.22 ± 9.93  48.60 ± 9.44  93.28 ± 18.63  76.18 ± 10.74  
Zeta-carotene 24.61 ± 5.36  16.92 ± 5.18  12.09 ± 4.56  18.49 ± 4.12  8.94± 3.10*  17.51 ± 3.88  15.47 ± 3.04 
Beta-carotene n/d  n/d  n/d  n/d  n/d  n/d  n/d  
 
1 n = 6-7/dosing group 
2 Significant differences between PE and LYC-dosed animal tissue concentrations at different time points versus cottonseed oil dosed animals at 6 hr post-dosing 
are denoted by an asterisk (*).    No significant differences between PE and LYC dosed groups at a specific time points were detected   Significant differences 
were detected using Tukey’s Studentized Range test within ANOVA. 
n/d = not detected 
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Table 4.9. Gerbil Prostate-Seminal Vesicle Complex Carotenoids 1,  2 
Hours Post-dosing:   6 12 24 
mean ± SEM(ng/g ) Cottonseed Oil  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  Lycopene Dose  Phytoene Dose  
Phytoene   n/d  n/d  n/d  n/d  n/d  n/d  n/d  
Z-Lycopene   35.94 ± 8.07 35.57 ± 5.31 30.46 ± 3.18  24.48 ± 2.18 39.52 ± 4.20 41.77 ± 13.28 31.06 ± 4.54 
all-E Lycopene 25.74 ± 2.83 26.42 ± 3.10 26.29 ± 2.42 19.78 ± 1.58A  35.62 ± 4.96B  29.79 ± 5.07  26.30 ± 3.58 
Phytofluene 12.12 ± 4.07  13.43 ± 5.23 9.54 ± 2.43 8.60 ± 1.34  8.22 ± 2.09  21.39 ± 9.47 9.41 ± 3.97 
Zeta-carotene 21.88 ± 1.97 24.26 ± 3.34  23.64 ± 1.80 17.33 ± 1.48A  30.80 ± 4.12B  27.04 ± 3.68 23.77 ± 3.14 
Beta-carotene n/d  n/d  n/d  n/d  n/d  n/d  n/d  
1 n = 6-7/dosing group 
2 Significant differences between PE and LYC-dosed animal tissue concentrations at different time points versus cottonseed oil dosed animals at 6 hr post-dosing 
are denoted by an asterisk (*).    Significant differences between PE and LYC dosed groups at a specific time point are denoted by a capital letter.   Significant 
differences were detected using Tukey’s Studentized Range test within ANOVA. 
n/d = not detected 
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CHAPTER 5:  
Overall impact of the dissertation accomplishments on the scientific field 
 
 Although tomatoes are a complex mixture of biochemicals, LYC has been assumed to be 
the major bioactive phytochemical in this fruit.  In order to better understand the contribution 
tomato carotenoids, including LYC, PE, PF, and ZC, to human health, a system for production of 
isotopically labeled LYC, PE, and PF tracers for use in mammalian carotenoid metabolism 
research was developed.  This work also sought to determine the bioaccumulation of tomato 
carotenoids in an appropriate animal model of human carotenoid bioavailability, the Mongolian 
gerbil.   
 This dissertation work has successfully established methods for efficient production of 
14C- and 13C-biolabeled carotenoids derived from tomato cell cultures treated with bleaching 
herbicides.  For animal and cell culture trials, production of 14C-carotenoids is most appropriate.  
To most efficiently produce 14C-carotenoids from tomato cell cultures, cultures should be dosed 
on day 1 of the 14 day growth cycle with 14C-sucrose and should be treated with an herbicide to 
promote carotenoid accumulation.  If labeled LYC is desired, cell cultures should be treated with 
CPTA on day one.  If labeled PE and PF are needed, cultures should be dosed with norflurazon 
on day 7 of the growth cycle.  If labeled LYC, PE, and PF are all needed these carotenoids can 
be simultaneously produced by treating cultures with CPTA and norflurazon.  For human 
metabolic tracing studies, 13C-labeled carotenoids may be produced using one of the herbicide 
treatments and cultures can be grown with uniformly labeled 13C-glucose to yield highly 
isotopically enriched carotenoids.  The availability of this tool for carotenoid tracer production 
will allow future advances in tomato carotenoid absorption and metabolism research, which was 
previously not possible.   
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 Through feeding gerbils 10% tomato powder diets and analyzing tissue and serum 
carotenoid accumulation, we have demonstrated that LYC, PE, PF, and ZC are bioavailable from 
tomato powder and are accumulated in substantial quantities (ng/g-µg/g), although not in the 
same ratios in each tissue.  By dosing gerbils with either PE or LYC, it was determined that over 
a 24 hr time period PE was more readily absorbed and led to greater tissue accumulation than 
LYC.  These differences in PE and LYC accumulation are hypothesized to be due to differences 
in bioavailability and/or metabolism.   
 Future studies should be performed to continue to improve on tomato cell culture 
methodologies as a source of isotopically-labeled tracers.  Such studies should focus on 
enhanced enrichment of isotopically-labeled carotenoids by sequentially growing tomato cells 
with [U]-13C-glucose to approach uniformly-labeled carotenoid production.  Additionally, a 
search for alternate approaches to increase yields of PF should be performed.  To follow-up on 
PE and LYC bioaccumulation observations, the gerbil should be provided with 14C-PE and 14C-
LYC doses to elucidate how these carotenoids are metabolized.  Similarly, based on findings 
obtained in gerbils, humans should be provided with 13C-PE, LYC, and PF to determine the 
relative bioavailability and metabolism of these carotenoids.  Collectively, this dissertation 
research contributed tools for elucidating the biochemical mechanisms of tomato carotenoid-
mediated prevention and attenuation of serious chronic diseases, including cardiovascular 
disease and prostate cancer. 
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